Role of nitric oxide in the regulation of tumor necrosis factor-alpha signalling by Barsacchi, Rico
Open Research Online
The Open University’s repository of research publications
and other research outputs
Role of nitric oxide in the regulation of tumor necrosis
factor-alpha signalling
Thesis
How to cite:
Barsacchi, Rico (2003). Role of nitric oxide in the regulation of tumor necrosis factor-alpha signalling. PhD
thesis The Open University.
For guidance on citations see FAQs.
c© 2003 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Rico Barsacchi 
Role of nitric oxide in the regulation of tumor 
necrosis factor-alpha signalling 
Thesis submitted in partial fulfilment of the requirements of the Open 
University for the degree of 
Doctor of Philosophy 
In 
Molecular and Cellular Biology 
January 2003 
DIBIT 
Department of Biological and Technological Research 
San Raffaele Scientific Institute 
Milan, Italy 
IMAGING SERVICES NORTH 
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
APPENDIX FROM PG 139 NOT 
DIGITISED BY 
REQUEST OF THE UNIVERSITY 
CONTENTS 
CONTENTS I 
ILLUSTRATIONS AND TABLES V 
ABSTRACT IX 
Chapter 1: INTRODUCTION 
1) CELL DEATH 
1.1) Apoptosis vs Necrosis: morphological features 
1 
1 
1.2) THE APOPTOTIC MOLECULAR MACHINERY: From Caenorabditis 
elegans to humans 4 
1.2.1) 
1.2.2) 
1.2.3) 
From CED-3 to caspases 
From CED-4 to Apaf-l 
From CED-9 to BcI-2 family 
4 
8 
10 
1.3) DEATH RECEPTORS ACTIVATE THE APOPTOTIC MACHINERY 15 
1.3.1) 
1.3.2) 
Signalling by CD95 
Signalling by TNFRl 
1.4) THE SPHINGOMYELIN CYCLE: AN INTRODUCTION 
1.4.1) Enzymes in the sphingomyelin cycle 
1.4.2) Ceramide and cell death 
1.4.3) Death receptors and sphingomyelinases 
1.5) NITRIC OXIDE 
1.5.1) Nitric oxide: an historical perspective 
1.5.2) 
1.5.3) 
Nitric oxide synthases: isolation and classification 
NOS: catalytical mechanism 
16 
19 
24 
25 
29 
32 
35 
35 
36 
39 
11 
1.5.4) 
1.5.5) 
NOS: sub-cellular localisation 
NOS: modulation of activity through phosphorylation 
1.6) NITRIC OXIDE AND CELL DEATH 
1.6.1) NO as a pro-apoptotic agent 
1.6.2) NO as an anti-apoptotic agent 
1. 7) AIMS OF THE THESIS 
Chapter 2: RESULTS 
Effect of exogenous NO on early signalling by TNF -(1 in U937 cells 
2.1) Time course of TNF -a triggered sphingomyelinases activation 
2.2) NO inhibits sphingomyelinases activation 
2.3) Contribution of sphingomyelinases to early features of apoptosis 
2.3a) Specificity of sphingomyelinases inhibitors 
2.3b) Caspase-8 activation 
2.3c) DNA fragmentation 
2.3d) Phosphatidyl-serine exposure 
42 
44 
45 
45 
49 
52 
56 
58 
60 
60 
63 
65 
68 
2.4) cGMP-dependent inhibition of acidic-sphingomyelinase accounts for apoptosis 
protection 70 
Effect of endogenous NO on TNF-(1 induced cell death in HeLalNOS tet 
off cells 
2.5) Construction and characterization of HeLaleNOS Tet-Off cell 
2.5a) 
2.5b) 
Transfection and Western Blot 
Sub-cellular localisadon of eNOS 
72 
72 
75 
III 
2.Sc) Transfected eNOS activity and cGMP assays 77 
2.6) eNOS expression modulates TNF-a induced cell death 81 
2.7) TNF-a stimulation increases eNOS activity and NO generation 85 
2.8) Role of sphingomyelinases in TNF-a -induced activation of eNOS 92 
Chapter 3: DISCUSSION 
3.1) Exogenous NO and TNF-a signalling 97 
3.2) Endogenous NO and TNF-a signalling 101 
3.3) Cross talk between NO and ceramide: an hypothesis 106 
Chapter 4: MATERIALS AND METHODS 
4.1) Materials 109 
4.2) Cell culture and treatments 110 
4.3) Measurement of sphingomyelinases activities in U937 cells 111 
4.4) Apoptosis detection in U937 cells 112 
4.4a) Western blot analyses of procaspase-8 and -3 112 
4.4b) Measurement of Caspase-8 activity 113 
4.4c) DNA fragmentation 113 
4.4d) Annexin-V staining 114 
4.5) Transfection and selection of HeLa cells conditionally expressing eN OS 114 
IV 
4.6) Western blot analysis in HeLa cells ll5 
4.7) Immunofluorescence in HeLa cells ll5 
4.8) Measurement of [Ca2+]c in HeLa cells ll6 
4.9) NOS Activity assays in He La Cells ll6 
4.10) cGMP measurements in HeLa cells ll7 
4.11) Apoptosis detection in He La cells 118 
4.12) Statistical analysis 118 
REFERENCES 119 
ACKNOWLEDGEMENTS 138 
APPENDIX: Pubblications 139 
v 
ILLUSTRATIONS AND TABLES 
Chapter 1) INTRODUCTION 
Figure 1.1 
Morphological features of apoptosis vs necrosis 3 
Figure 1.2 
Schematic model of caspase activation 7 
Figure 1.3 
Topology of Apaf-l interacting proteins 9 
Figure 1.4 
C.Elegans model for Bcl-2 family proteins action 13 
Figure 1.5 
Evolutionary conservation of programmed cell death genes 14 
Figure 1.6 
Model for Fas triggered apoptosis 18 
Figure 1.7 
Model for TNF -a triggered apoptosis 21 
Figure 1.8 
A summary of apoptosome regulation 22 
Figure 1.9 
Sphingolipids structures and enzymes of metabolism 26 
Figure 1.10 
Proposed mechanism for TNF-a triggered activation of SMases 33 
Figure 1.11 
Relationship among the polypeptide sequence for NOS isoforms and cytochrome P450 
reductase 38 
Figure 1.12 
Schematic representation of NOS reaction sequence 39 
Figure 1.13 
Central role ofCalmodulin (CaM) in NOS activity 41 
Figure 1.14 
Signaling components characterizing NO-triggered apoptosis 48 
VI 
Figure 1.15 
Effects of ceramide,NO and cGMP on TNF-a-induced TRADD recruitment to TNF-Rl 
53 
Figure 1.16 
Effects of NO and cGMP on TNF-a-induced ceramide generation. 54 
Fig. 1.17 
Effects of exogenous ceramide, NO, and cGMP on TNF-a-induced apoptosis. 55 
Chapter 2) RESULTS 
Figure 2.1 
Time course of activation of A-SMase (A) and N-SMase (B) by TNF-a in U937 cells 57 
Figure 2.2 
NO inhibits TNF-atriggered A-SMase and N-SMase activities through the generation of 
cGMP and the activation of Protein Kinase G 59 
Figure 2.3 
Specificity of action of drugs on A-SMase activity triggered by TNF-a 61 
Figure 2.4 
Specificity of action of drugs on N-SMase activity triggered by TNF-a 62 
Figure 2.5 
Involvement of A-SMase in caspase 8 activation triggered by TNF-a./CHX. 64 
Figure 2.6 
Involvement of A-SMase in DNA fragmentation triggered by TNF-a./CHX 66 
Table 2.1 
Inhibition by cGMP and potentiation by A-SMase of TNF-a-induced apoptosis are 
transient events 67 
Figure 2.7 
Involvement of A-SMase in phosphatidyl-serine exposure triggered by TNF-a./CHX 69 
Figure 2.8 
Inhibition of A-SMase by 8Br-cGMP accounts for its ability to reduce TNF-a./CHX 
triggered caspase-8 activation and DNA fragmentation 71 
Figure 2.9 
Immunoblots of protein from HeLa tet-off cells. 74 
VII 
Figure 2.10 
Double-staining immunofluorescence of HeLa tet-off cells 76 
Figure 2.11 
Characterization of eNOS activity in He La tet-off cells 79 
Figure 2.12 
cGMP generation in the HeLalPC12 reporter system 80 
Figure 2.13 
Effect of eNOS expression on TNF-a induced phosphatidyl-serine exposure 82 
Figure 2.14 
Effect of eNOS expression on TNF-a induced hypodiploid DNA increase 83 
Table 2.2 
effects of eNOS expression on the TNF-a-induced exposure of phosphatidyl-serine and 
formation of hypodiploid DNA 84 
Figure 2.15 
Effect ofTNF-a treatment on NO generation in HeLa/tet-off cells 86 
Figure 2.16 
eNOS activation by TNF-a involves Pi3K activation. 87 
Figure 2.17 
Different pathways of activation of eNOS 90 
Figure 2.18 
Patterns of Akt (A) and eNOS (B) phosphorilation by different stimuli 91 
Figure 2.19 
TNF-a activation of SMases in HeLa tet-off cells and specificity ofSMase compounds 94 
Figure 2.20 
TNF-a triggered phosphorilation of Akt and eNOS is downstream to N-SMase: Western 
Blot analysis. 95 
Figure 2.21 
TNF-a triggered activation of eNOS is downstream to N-SMase: Arginine/Citrulline assay 
96 
Figure 2.22 
TNF -a triggered SMase activation is Pi3K independent 96 
VIII 
Chapter 3) DISCUSSION 
Figure 3.1 
NO/cGMP dependent inhibition of SMases and of TNF-a triggered early apoptotic 
signalling 100 
Figure 3.2) TNF-a activates eNOS through a N-SMaselPi3KJAkt dependent signalling 
p~w~ 1~ 
Figure 3.3 
Hypothetical model of cross-talk between NO and SMase in regulation ofTNF-a triggered 
apoptosis 108 
IX 
ABSTRACT 
Tumour Necrosis Factor-a (TNF-a) triggers cell death via apoptosis through a well defined 
signaling pathway activated by its p55 kDa receptor. The problem of the modulation of this 
signaling by intracellular second messenger is, on the contrary, a very debated and open 
field. In a previous paper (De Nadai et ai, 2000) we have shown that the lipidic messenger 
ceramide is able to increase recruitment of the TRADD protein to the p55 kDa receptor, 
caspase-8 activation and thus apoptosis. In the same paper we have shown that nitric oxide 
was able to inhibit these same features but the mechanisms through which nitric oxide and 
ceramide interact, however, are unclear. 
I have studied the contribution of ceramide-generating enzymes, i.e. the acidic and neutral 
sphingomyelinases (A- and N-SMase), to the apoptotic response to TNF-a, as well as their 
cross-talk with NO in two different cellular systems, the pro-monocytic cell line V937 and 
HeLa cells stably trasfected with bovine eNOS cDNA under the control of a tetracycline 
repressed promoter (HeLa-eNOS tet-off cell line). 
In V937 cells, TNF-a rapidly triggered both A- and N-SMase activity. Cells pre-incubation 
with the NO donor SNAP inhibited activation of both enzymes. These effects of the NO 
donor were mimicked by 8-Br cyclic GMP, and reverted by the guanylate cyclase inhibitor 
ODQ. A-SMase inhibitors reduced TNF-a triggered caspase-8 activation, while inhibition 
of N-SMase resulted in no effect. In HeLa cells eNOS expression was found to exert a 
protective effect on TNF-a induced apoptosis and, moreover, TNF-a was found to activate 
eNOS through a N-SMaselPi3KJAkt dependent signalling pathway. 
These results suggest the existence of a regulatory loop in which NO and ceramide acts in 
concert in order to modulate TNF -a signalling. 
Introduction 
Chapter 1 
INTRODUCTION 
1) CELL DEATH 
Programmed cell death (apoptosis) is an ubiquitous process that plays a fundamental role 
both in physiology and pathology: it is a key player both during embryological 
morphogenesis as well as in adult stages of the organism, where it regulates crucial events, 
e.g. tissue turnover and immune response, thereby contributing to the homeostasis of the 
organism (Raff, 1998). Its dis-regulation may cause or contribute to the onset of various 
pathological states, such as neuro-degenerative diseases (e.g. Alzheimer disease) or cancer 
(Honing and Rosenberg, 2000; Cory and Adams 2002). 
The first experimental definition of apoptosis took origin from observation carried out 
during experiments of liver degeneration: Kerr and collaborators induced liver atrophy in 
the rat by tying off a large branch of the portal vein and described a discrete demise of cells 
characterized by a sequence of changes defined first as shrinkage necrosis and then as 
apoptosis (Kerr et ai, 1972). This and a number of subsequent critical observations opened 
the way to an enormous increase in interest regarding apoptosis, with the definition of both 
its morphological and biochemical features, especially in opposition to the other known 
form of cell demise, i.e. necrosis. 
1.1) Apoptosis vs Necrosis: morphological features 
The most important feature of apoptosis is represented by the stereotyped sequence of 
morphological and biochemical events that literally make the cell disappear upon the death 
stimulus. These events can be triggered by either an internal clock or by extracellular 
factors such as hormones, cytokines and other chemical and physical agents. 
Briefly, the cell starts to lose volume rapidly, detaching from it s social environment and 
profoundly modifying its plasma membrane characteristics, with the exposure of 
components normally hidden or little expressed, important for dying cell recognition by 
macrophages. The internal organization of the cell is maintained, at least in the initial 
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phases of the process, while the most evident events occurs at the nuclear level: the 
nucleolus and basal lamina disgregate, chromatin condenses and is cut in 200 bp (or 
multiple of this) fragments, representing the length of the DNA inter-nucleosomic traits. 
Discrete chromatin fragments thus formed move toward the plasma membrane, where they 
are engulfed by the membrane itself to form apparently discrete structures: these events 
give rise to blebbed shape of the cell as observed by both light and electron microscopy. 
Blebs detach from the cell body, engulfing part of the cytoplasm and of the nuclear 
material, and form the so-called . apoptotic bodies·· recognized and phagocytosed by 
bystander cells. A particular feature of this process is that it happens without spilling of 
cytosolic content to the extracellular milieu, and without causing any inflammatory reaction 
(Fig 1.1 A and C). 
All this process is very different from necrosis, which represents a passive process, the 
consequence of gross injuries to the cell. When a cell dies by necrosis early changes can be 
identified at the level of the plasma membrane which shows progressive discontinuities, 
causing abrupt swelling and organelle disruption. (Fig 1 B and D). The cytoplasm and the 
plasma membrane are the first targets of the necrotic process, while the nucleus, at variance 
with what is observed during apoptosis, appears relatively preserved. 
When cultured cells are analysed by light or fluorescence microscopy, apoptotic cells have 
a distinct appearance from necrotic cells with differences that mainly concerns shape and 
structure: the final stage of apoptosis is cell splitting in numerous fragments, whose most 
common final fate in the organism is to be engulfed by phagocytes. In contrast, no cell 
fragmentation appears in the course of necrosis. Rather what happens is a general cell 
hydration process, followed by cell disruption. Electron microscopy provides a detailed 
characterization of both phenomena, as illustrated in Fig 1.1. 
A very simplified, but useful view that we could have from this brief morphological 
description of the two different type of cell death is that necrosis represents a passive 
response to an insult, with the cell literally exploding in an uncontrolled way, while 
apoptosis represent an active response to death stimuli activating a complex machinery 
strictly controlled by an evolutionary conserved genetic background. Such machinery will 
be described in the next section 
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Figure 1.1) Morpholog ical features ofapoptosis vs necrosis 
A) Transmission Electron Mi croscope (TEM) image of an apoptotic ce ll (A) compared 
with a n0I111al cell (N) : hromatin packaging clea rl y appears in A, trongly different 
from its normal arrangement. The good preservation of membrane and organelles is 
also different (magnifi cat ion : x 8000) . 
8 ) TEM image of a necrotic cell : the disruption of pia ma membrane and organelles is 
clea rl y observable, while the nucleus is r taining it normal morphology 
(magni fication: x 8000) 
C) 'canning Electron Microscopy (SE M) image of an apoptotic ce ll : the pia ma 
membrane appea rs homoge nously preserved, while it is clearly visible surface 
blebbing (magni fi cation : x5 000) 
D) SEM image of a nec rotic cell: The plasma membrane shows numerou le ions 
(magni fi cation : x5000) 
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1.2) THE APOPTOTIC MOLECULAR MACHINERY: From Caenorhabditis 
elegans to humans 
Most of the knowledge about the basal mechanism responsible of programmed cell death 
derives from the genetic analyses carried out in the nematode worm Caenorhabditis 
elegans. Onset and progress of development in this animal is very well defined, with 1090 
cells that constitutes the adult body and 131 cells that die in the course of development. The 
unraveling of this sophisticated plan was important because it permitted to easily identify 
and characterise all mutants bearing abnormalities in cell number and survival upon 
development of the whole organism, and thus to define the role of each gene and its product 
in the apoptotic process. 
Caenorabditis mutants aberrant in the death genetic program depend on in three principal 
genes, the so-called Cell Death genes (ced genes), whose products operate the regulation of 
cell death. CED-3 and CED-4 act to kill cells, while CED-9 suppresses killer genes action 
(Hengarter et ai, 1994). 
CED-3 has been surprisingly identified as a proteolytic enzyme, a protease (Yuan et ai, 
1993), CED-4 was found to act as a positive regulator of CED-3, being able to bind it and 
to promote its proteolitic activity. In contrast CED-9 was identified as a CED-3 negative 
regulator, since it is able to bind CED-4, thus preventing the activation of CED-3 
(Chinnaiyan et ai, 1997). What happens normally is that CED-9 is complexed with CED-3 
and CED-4 keeping CED-3 inactive. The apoptotic stimuli cause dissociation of CED-9, 
allowing the activation of the CED-3 protease and thereby committing the cell to die by 
apoptosis. 
This simplified mechanism represents the prototypic model from which the much more 
complex cell death machinery of the higher organisms has emerged, as described below. 
1.2.1) From CED·3 to caspases 
The protein encoded by ced-3 gene is very similar to the human interleukin.l·converting 
enzyme (ICE) protein (¥uan et ai, 1993; Thornberry et ai, 1998), an intracellular protease 
that cleaves interleukin-I, a signalling protein inducing inflammation, out of a larger 
precursor protein. Recognition of the similarity between CED-3 and ICE proteins was 
actually the first indication that the apoptotic programme is dependent on proteolysis. Very 
soon, starting from this similarity, new members of the CED-3/ICE family of proteases 
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were identified. many of which become activated during apoptosis (Nicholson et ai, 1997). 
These proteases share two conserved features: all of them are cysteine proteases containing 
a conserved QACXG penta-peptide. including the active-site cysteine (Cohen 1997); and 
all of these enzymes have a unique strong preference for cleaving peptide bonds C-terminal 
to aspartate residues. For these reasons, these enzymes have been collectively called 
cysteine-aspartate proteases, caspases (Alnemri et ai, 1996). Up to date, the caspase family 
of proteases consists of at least 14 mammalian members that are constitutively expressed in 
almost all cell types as inactive proenzymes (zymogens) that became processed and 
activated in response to a variety of pro-a pop to tic stimuli. 
Pro-caspases (32-56 kDa) contain four domains: an N-terminal prodomain, a large subunit 
(17 -21 kDa), a small subunit (10-13 kDa) and a short linker between the large and small 
subunits (Figure 1.2; Earnshaw ai, 1999). Caspase activation involves a proteolytic 
processing of the proenzyme at specific aspartate residues between domains, resulting in 
removal of the prodomain as well as the linker region, with formation of a heterodimer 
containing a large and a small subunit (Liang and Fesik, 1997). The active caspase is a 
tetramer composed by two such heterodimers. 
The importance of caspases for the apoptotic process has been clearly demonstrated by 
several independent findings, among which: 
i) Over-expression of caspases has a severe cytotoxic effect (Chang and Yuang, 
2000) 
ii) Caspase inhibitors are able to effectively inhibit apoptosis induced by various 
stimuli (Ekert et ai, 1999) 
iii) Knock-out animal models lacking caspases shows profound defects in apoptosis 
(Zheng and Flavell, 2000) 
Caspases diner in their substrate specificity and can be divided into three subgroups, based 
on preferred tetra-peptide sequences after which active enzymes cleave their respective 
substrates. The P4 site (that means 4 aminoacids N-termit:tal to the cleavage site) is the most 
critical determinant of substrate specificity. 
Caspases of group I (caspase-l, -4 and -5) cleave preferentially after the WEHD motif, 
group 11 (Caspase-3 and -7)) after DEXD, whereas the optimal cleavage sequences for 
caspases belonging to group III (caspase-6, -8, -9 and -10) are the (IlL/V) EXD motifs 
(Thornberry et ai, 1997). Only caspase-2 cleaves preferentially after the penta-peptide 
sequence VDV AD; the cleaving sites for caspases-ll, -12, -13 and -14 are not yet known. 
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Evidence for the sequential activation of caspases has lead to the concept of a caspase 
cascade (Hi rata et aI, 1998). During apoptosis, initiator caspases are thought to be initially 
auto-catalitically activated in response to apoptogenic stimuli. Subsequently, they transmit 
the signal by cleaving, and thereby activating, downstream effector caspases that proceed to 
the cleavage of other specific proteins in order to . dismantle" the cell (Salvesen and Dixit, 
1999). 
Among caspase substrates are cytoskeletal proteins, such as lamin and actin, cytoskeletal 
regulators, such as focal adhesion kinase (F AK; Wen et ai, 1997) or gelsolin (Kothakota 
et aI, 1997), and proteins involved in DNA repair and cell cycle regulation, such as 
polyADP-rybose polimerase (PARP) or the retinoblastoma (Rb) protein, respectively 
(Chang and Yang, 2000). Caspases also activate a DNA-cleaving enzyme (a DNAse) by 
cleavage of an inhibitory sub unit enabling the enzyme (called CAD for caspase-activated 
DNAse) to cut DNA in the nucleus (Enari et aI1998). A survey of these caspase substrates 
indicates that caspases participate to the apoptotic cell death programme in a very 
coordinated manner which includes the following sequence of events: cut off of contacts 
with surrounding cells, reorganization the cytoskeleton, shut down of DNA function and 
structure, and finally disgregation of the cell into apoptotic bodies, that are engulfed by 
macrophages and bystander cells. 
Most experimental models of apoptosis involve the activation of caspases, and until now no 
activation of caspases has been found in the context of necrotic cell death (Armstrong et 
aI, 1997); yet, apoptosis may occur in the absence of caspase activation. Because of this, 
detection of caspase activation in cells is considered as a good discriminating criterion to 
distinguish the two types of cell death, concerning at least the early features of cell death. 
Cleavage sites r-
Activation 
by cleavage 
Prodomain 
Figure 1.2) Schematic model of caspase activation 
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1 
COOH 
Inactive procaspase precur or I 
Small subunit 
I Activated ca pasc I 
The whole protein is constituted by a large inactive precursor. the pro-caspa e, which is 
activated following a proteolytic cleavage at two particular a partic acid re idues , with 
removal of the prodomain and formation of the large and mall subunit . The e ubunit 
forms a heterodimeric complex to form the complete active enzyme. There are evidences 
that a complete enzyme is con tituted by a complex made up from two large and two small 
subunits (not shown) 
Adapted from (Raff, 1998) 
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1.2.2) From CED-4 to Apaf-1 
The human CED-4 homologue has been identified by Zou and collaborators (Zou et ai, 
1997) by an in vitro reconstitution approach, and has been termed apoptotic protease 
activating factor (Apaf-l). It has been shown to participate in the cytochrome c (cyt-
c )/dA TP-dependent activation of caspase-3 through the proteolytic activation of caspase-9 
(Li et ai, 1997). 
In terms of biochemical features, Apaf-l possesses an amino-terminal CED-3 like domain, 
which includes a caspase recruitment domain, a CED-4 like domain containing a conserved 
P-Loop, and a long carboxy-terminal domain extremely rich in WD-40 repeats, involved in 
protein-protein interactions. A number of pro- and anti-apoptotic factors have been shown 
to interact with some of these domains mediating interactions of Apaf-l with other 
components of the apoptotic machinery (Figure 1.3). A quite interestingly Apaf-l network 
is the Bclx/ Apafl /Casp-9 complex, which represents the vertebrate counterpart of the CED-
9/CED-4/CED-3 ternary complex, the primordal apoptosome observed in C.elegans 
(Chinnayan et ai, 1997). 
Apaf-l is an important player in the activation of caspase-9 in a pathway that involves cyt-
c. The latter is required for the formation of a complex, sufficient to activate caspases even 
in cell-free extracts (Liu et ai, 1996). In vitro binding of Apaf-l, pro-caspase-9 and cyt-c, 
in the presence of ATP, results in the activation of caspase-9. However the exact target site 
of cyt-c in Apaf-l, as well as its action, has not yet been precisely defined. Currently, 
because of its homology to CED-4, which has ATPase-like functions (Aravind et ai, 
1999), Apaf-l is considered to be an ATPase, crucial to its role in caspase activation 
(Chaudary et ai, 1998). Conversely, a truncated form of Apaf-l, lacking the WD-40 
domain, is able to promote caspase-9 activation in the absence of cyt-c or dATP 
(Srinivasula et ai, 1998). Taken together, these observa~ion indicate that cyt-c, dATP and 
the WD-40 domain are involved in the conformational changes of Apaf-l that are necessary 
to induce caspase-9 activation 
The observations summarized above provide evidence for an evolutionary conservation 
among C. elegans and vertebrates of the basal apoptotic machinery at a biochemical and 
cellular level. The importance of apoptosis in development grows with the complexity of 
the organism. Although with nearly 20% more cells, apoptosis deficient worms can have a 
normal life span. By contrast, the various caspase KO mice all die because of several 
I/ltroductio/l 9 
abnormalities resulting from apoptosis deficiency (Zhcn g and Flavc ll , 2000) . The Apaf- I 
defic ient mice follow thi s rul e, hav ing a mass ive developmental phenotype: they die 
be tween embryonic day 16 and post-natal day O. ex hibiting reduced apoptosis in the brai n 
and dramatic cranio-fac ial alterations (Cecconi et ai, 1998). 
These resu lts strongly indi cate that Apaf-I and caspase 9 are components of the sa me 
apoptotic pathway. resembling the C elegans situat ion, whcre ED-4 was ab le to activate 
CE D-3. 
c:af1 
Figure 1.3) Topology of Apaf- I interact ing protein 
Apaf- I protein is composed of three domain , an N-terminal caspa e recruitment domain 
(CA RD), an Ap-ATPase domain (CED-4 like) and a WD-40 repeats domain (WD-40) for a 
molecul ar weight of 135 kDa. The apoptosome components are depicted in clo e prox imity 
of their potential interaction site with Apaf- I domains. dA TP is an e sential cofactor for 
Apaf-I acti vity. The arrow indicates the potenti al of APAF- l to get it NH2 and COOH 
terminu into contact, with different functional implications. 
Adapted from (Cecconi, 1999) 
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1.2.3) From CED-9 to BcI-2 family 
As previously seen, the genetic analysis of the nematode C.elegans revealed two loci, ced-3 
and -4, essential for programmed cell death during development. The thirdt'ed-9, was 
found to be a regulator of their action. If ced-9 is inactivated, most of the cells in the 
developing worm die. Quite remarkably, however, if also ced-3 or ced-4 are inactivated, the 
worm and all of its cells remain alive (Adams et ai, 1998). CED-9 appears so to represent a 
true regulator of the apoptotic machinery. The first mammalian regulator emerged when 
bcl-2, a gene activated by chromosome translocation in human follicular lymphoma, was 
unexpectedly found to permit survival in a quiescent state of cytokine-dependent 
hematopoietic cells, in the absence of cytokine (Vaux et ai, 1988). 
Bcl-2 and CED-9 are functional and structural homologues. The similarity is so strong that 
when the human bC/-2 gene is artificially introduced in the worm it can functionally 
substitute for CED-9, thus inhibiting apoptosis (Vaux et ai, 1992). The discovery of Bcl-2 
has fostered identification of a large family of proteins with different, and sometimes 
counter-acting functions. At least 15 protein members of the family have been identified up 
to date in mammalian cells, falling into three distinct groups. Bcl-2 and several close 
relatives are able to exert apoptosis inhibition (Vaux et ai, 1988), whereas structural similar 
relatives such as Bax (Gross et ai, 1999) and distinct cousins such as Bik and Bim instead 
fosters death (Kelekar and Thompson, 1998). 
The various subfamilies share sequence similarities: Bcl-2 and Bax subfamilies share three 
of four conserved Bcl-2 homology sequence motifs (BH motifs), and can assume a similar 
conformation (Sattler et ai, 1997). In contrast, members of the third subfamily share only 
one domain (BH3) and are unrelated even to one another. Most members of the wider clan 
possess a hydrophobic C-terminal segment, which facilitates their interaction with the 
endoplasmic reticulum, nuclear envelope and outer mitochondrial membranes, where the 
pro-survival members normally reside, and where they assemble during apoptosis. 
Members of the pro- and anti-apoptotic families are able' to heterodimerize: the BH3 helix 
of the apoptogenic proteins can bind to a hydrophobic groove in the pro-survival proteins, 
created by a-helices in the BH3, BH 1 and BH2 regions. Thus BH3-only proteins can serve 
as ligands that lock a pro-survival protein into an inactive conformation. In essence: 
interactions between two proteins with opposite roles result in inhibition of each other 
function. The ratio of suppressor-to-promoter determines the cell susceptibility to 
apoptosis. 
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Genetic studies indicate that without a Bcl-2 type guardian, most cells of the metazoans are 
primed to death: in C.Elegans, the ced-9 gene is required for embryogenesis, apparently 
because the lack of CED-9 permits activation of CED-3 by CED-4 (Horvitz, 1999). 
Disruption of the mammalian pro-survival genes, by contrast, produces phenotypes only in 
specific tissues (Adams and Cory, 1998), presumably due to their redundancy and 
partially overlapping expression patterns. 
The exact biochemical mechanism by which the pro-survival Bcl-2 family members exert 
their function is still debated. For example, it has not been clarified whether these proteins 
keep the caspase activators in check directly or indirectly: results from the C.elegans 
model, moreover, favour a direct sequestration model as shown in figure 1.4. In this model 
CED-4 co-localizes with CED-9 on mitochondria until a death signal induces the 
displacement of CED-4, which then activates CED-3 (Chen et aI, 2000). It therefore seems 
plausible that CED mammalian homologous also associate. 
Bcl-xl was initially reported to interact with Apaf-l; further studies did not provide 
evidence for any such complexes (Moriishi et ai, 1999) and supported the conclusion that 
Apaf-l is a monomeric cytosolic protein (Haussman et ai, 2000). Nevertheless, CED-9 and 
its mammalian homologues must act similarly, because a bcl-2 transgene can rescue cells in 
CED-9 deficient nematodes (Hengarter and Horvitz, 1994). 
Alternative models suggesting an indirect mode of function for Bcl-2-like proteins are 
recently gaining momentum. In particular it has been proposed that Bcl-2 governs caspase 
activation indirectly through effects on organelIes, in particular mitochondria. Bcl-2 over-
expression precludes all mitochondrial disturbances associated with apoptosis, such as pH, 
membrane permeability and outer membrane integrity (Green and Reed, 1998). The 
mitochondrial inter-membrane space contains several apoptogenic proteins and their release 
might represent the most important death signal. Cyt-c has been the first recognized 
apoptogenic signal escaping from the mitochondria. It represents therefore a critical co-
factor (together with ATP) for the activation of caspase-9. by Apaf-l (Liu et ai, 1996). 
Data emerging from the identification of the tri-dimensional structure of a Bcl-2 family 
member may contribute to give an answer to the question of how Bcl-2 are able to affect 
mitochondria: the resemblance of the 3D structure of Bcl-xl to that of membrane 
penetrating bacterial toxins lead to the hypothesis that all family members possessing 
hydrophobic BH I-BH2 domains might form pores in organelle membranes (Kelekar and 
Thomson, 1998). This feature has been shown with lyposomes. Whether this occurs in live 
cells remains to be established. While it is easy to explain how the pore-fonning activity 
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leads to the cytotoxic effects of Bax-like proteins, it is more difficult to foresee how pores 
formed by Bcl-2-like molecules might protect cells. 
Rather than forming new pores in the mitochondria, Bcl-2 family members might stabilize 
the pre-existing channels through which adenine nucleotides and other small molecules 
traffic occurs, i.e. the ·permeability transition pore··, that is believed to form across sites of 
contact between the inner and outer membranes (Crompton, 1999). The open channel 
allows passage of molecules up to 1500 daltons and the pore in the outer as well as in the 
inner membrane appears to be gated (Vander Heiden, 2000). Opening of the inner 
membrane channel can dissipate the H+ gradient across the membrane, uncoupling the 
respiratory chain from A TP production. The resulting matrix swelling was proposed to 
rupture the outer membrane (Vander Heiden et ai, 1997), but neither swelling nor rupture 
has been clearly shown to be common feature of apoptosis (Von Ahsen et ai, 2000). 
Moreover, evidence of permeability transition pore activation is still lacking. 
Despite the amount of studies regarding the Bcl-2 family of proteins the whole picture of 
interactions between the various family members is not known in detail, and many 
questions remain open. Much remains to be understand about the role of BH3 containing 
proteins, and about how damage signals are sensed. For Bax-like proteins, the questions 
regard the mode of activation, whether they are activated by BH3-only ligands such as Bid; 
whether they represent a trigger or an amplification mechanism for apoptosis. In addition it 
is not yet clear whether they mediate death primarily by compromising their pro-survival 
relatives, by activating caspases independently or by disruption of mitochondrial function. 
For the pro-survival proteins, open issues are how the heterodimerization is able to alter 
them, how their function in the ER and nuclear envelope affect the mitochondria and the 
nature of their immediate downstream effectors. 
A recent progress in the ER field has demonstrated that in cells over-expressing Bcl-2 the 
cistaemae content of Ca2+ is significantly reduced (Marsden et ai, 2002). On activation of 
Ca2+ release, therefore influx is smaller and this protects. mitochondria from Ca2+ damage. 
Although the mechanism of Bcl-2 action on ER membranes is not yet clear (leakage?) this 
ER process appears to play a relevant role in the effect of the oncogene. 
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Figure 1.4) CElegans model for Bcl-2 family protein action 
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A) In living cells, the ED-9 protein form a complex with CED-4, inhibiting it from 
aggregating and interacting with the CED-3 pro-ca pa e. 
B) In dying cells, an apoptosi -promoter of the Bcl-2 family (h re i EGL-l d picted) 
bind to CED-9, relea ing it from the compl x with CED-4 and ED-3. ED-4 is so 
able to aggregate, leading the bound CED-3 molecule clo e enough to xert their 
auto-activation, following the proximity activation model. 
In the context of thi model the variou complexe are probably bound to intracellular 
membrane by CED-9. 
Adapted from (Raff, 1998) 
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Apart from these open questions, the informat ion summari zed in this chapter clea rl y 
hi ghli ghts an important feature of th e apop toti c mac hinery, i.e. its evo lutionary 
co nse rva ti on from the worms to hi gher vertebrate animals. It is clear that the basal 
machinery se rves as a sort of groundstone upon which evolution built up a progress ively 
more intricate network regulating cell death, able to respond to increas ingly complex 
demand s of the organisms .. An exa mpl e of how novel playe rs are integrated in thi s 
evo lutionary conserved pathway is exempli fl ed by the o-called ' instructi ve" apoptosis, 
which will be described in the following section , and whose modulat ion wi ll be the centra l 
point of thi s thesis. 
C. elegans 
EGL-1 CED-9 CED-4 CED-3 
--1 --1 ~ DEATH 
BAX BClXL APAF1 
BID BCL2 CASP9 
CASP3 
Mamlnals 
Figure 1.5) Evolutionary conservation of programmed cell death genes 
This diagram schematically represents the conservation of the apoptot ic genetic program. 
The upper diagram shows the order of function of ced gene in C.elegan whi le the lower 
diagra m shows the conserved mechani sms in mammals, where due to the complex ity of the 
organisms, entire gene families play the counterpart roles of C.elegans protein 
Adapted from (Cecconi, t 999) 
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1.3) DEATH RECEPTORS ACTIVATE THE APOPTOTIC MACHINERY 
Cells are able to integrate signals coming from either the environment or from the 
intracellular milieux in order to keep their survival machinery in check: loosing contacts 
from the surroundings or an internal damage (such as DNA damage) trigger the initiation of 
apoptosis (Evan et ai, 1998). Remarkably, mammals have also evolved another mechanism 
to actually direct individual cells to death, which is based on a receptorial protein system, 
the so-called Death Receptors. These receptors play a key role in instructive apoptosis, 
which is particularly important in the immune system (Osborne, 1996), because they are 
able to connect extracellular signals to the apoptotic machinery. As a whole the process 
stems evolutionary from the one described in the previous section. This is a nice example of 
how nature is able to integrate pre-existing signalling modules with novel emerging 
necessity, in order to provide appropriate answers to novel biological demands. 
Death receptors belong to the tumor necrosis factor (TNF) receptor gene superfamily, 
defined by the presence of conserved domains in the proteins they code for. These proteins 
contain from 2 to 6 repeats of cysteine-rich extracellular sub-domains, which represent also 
the portion of the each protein sharing the highest similarity with the other family members; 
in addition, they contain a homologous sequence which codes for an approximately 80 
aminoacid domain near the carboxy-terminus of the protein, which has been named the 
death domain (DD; Tartaglia et ai, 1993) and which has the tendency to self-aggregate. 
The DOs act as modules mediating ligand-dependent recruitment of other DD-containing 
proteins. The latter are crucial to propagate the signal from outside to inside the cell and 
have an obligate role in inducing cyto-toxicity, enabling receptors to engage the cell s 
apoptotic machinery, once they are activated. 
The tertiary structure of the death domains has been resolved by heteronuclear 
multidimensional Noise Magnetic Resonance (NMR) spettroscopy, showing that it includes 
a protein fold consisting of six antiparallel, amphipati~ a helices (Huang et ai, 1996). 
Many charged amino acids are present on the surface of this structure and this is probably 
the structural reason responsible for mediating the interaction between various DOs. DOs 
have been conserved through metazoan evolution: they share limited homology with the 
protein product of the Drosophila reaper gene, originally identified by deletion mapping 
studies as a gene essential for many cell deaths occuring during normal Drosophila 
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embryogenesis (Golstein et ai, 1995). Deletion of reaper not only blocks developmental 
cell death but also suppresses cell death in response to X-ray-irradiation. 
Death receptors compose a large family, with the best-characterized examples being CD95 
(also named Fas or APO-l) and the p55 KDa receptor for TNF-a. (TNF-RI). The signal 
transduction of these two receptors will be briefly described below. 
1.3. t) Signalling by CD95 
CD95 and its ligand, CD95L (or Fas ligand) plays an important role mainly in three types 
ofphysiologic apoptosis: 
i) peripheral deletion of activated mature T cells at the end of the immune 
response. 
ii) killing of targets such as virus-infected cells or cancer cells by cytotoxic T -cells. 
iii) killing of inflammatory cells at immunoprivileged sites such as the eye. 
The biological importance of CD95has been determined from mouse KO as well as from 
human pathologies in which expression of inactive defective genes for CD95 or CD95L 
leads to accumulation of peripheral lymphoid cell and to a fatal autoimmune disease 
characterized by massive enlargements oflymphnodes (Nagata, t 997). 
CD95 is a type-I membrane protein with a homotrimeric structure: its ligand has a trimeric 
structure and each CD95L trimer binds to three molecules of the receptor. Since death 
domains have the tendency to associate one with the others, the binding of CD95 triggers 
the clustering of receptor s death domain, a finding supported by nuclear magnetic 
resonance structure analysis and mutagenesis studies (Hll;ang et ai, t 996). 
An interacting protein, the Fas-Associated Death Domain (FADD; named also Mortl), was 
identified with the yeast two-hybrid system, using the Fas cytoplasmic region as a bait. This 
protein, through it s own death domain and following the conformational change of the 
activated receptor, is able to bind to clustered receptor death domain (Chinnaiyan et ai, 
1995). 
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FADD N-terminal region contains also another important domain, the Death Effector 
Domain (DED), responsible for executing downstream signal transduction. In fact, DED 
represents an example of a more global homophilic interaction domain termed CARD (as 
for Caspase Recruitment Domain) found in several caspases and able to bind to a similar 
domain present in a repeated fashion within the zymogen form of caspase-8 (also called 
FLICE, or MACH) (Boldin et ai, 1996). Following recruitment operated by FADD, pro-
caspase-8 activates itself through self-cleavage (Muzio et ai, 1998) and triggers the 
activation of downstream effector caspases, such as caspase-9 (which is the mammalian 
homologue of the nematode protein CED-3) resulting in an amplification effect that 
commits the cell to apoptosis (see Figure 1.6 for a schematic model of CD95 signalling). 
The key role played by F ADD in cell death signal have been confirmed by the F ADD gene 
KO mice (Zhang et ai, 1998) and by transgenic mice expressing in T -cells a dominant 
negative mutant of F ADD (Newton et ai, 1998). Both these studies demonstrate the 
obligate role of FA DD in the CD95 triggered cell death. 
A 
Fas Ligand 
Fae 
Death Domain 
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Various Caspase susbstrates 
~ (FAK, PARP, Rb, 
Lamin, Actin etc) 
/ 
Degradation of Chromosomal DNA 
Figure 1.6) Model for Fas triggered apoptosis 
Binding of Fas ligand to it receptor induces a tightening of its structure, with a 
concomitant conformational change, which cause the recruitment of caspa e-8, via the 
adaptor protein FADD/MO RTI. The oligomerization of caspase-8 results in it elf-
activation with the activation of the [CE protea e ca cade. The activated down tream 
caspases can cleave various substrates, such as Poly(ADP)ribo e polymera e (PARP), focal 
adhesion kinase (F AK), lamin, actin and various other causing the morphological changes 
of the cell and leading to it apoptotic demise 
Adapted from (Nagata, 1997) 
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1.3.2) Signalling by TNFRl 
The sequence of events following TNF receptor (TNFRI) engaging by its ligand is similar 
to that described for CD95 with some other important players in the game (see Figure 1.7 
for a schematic model). 
Upon the binding with TNF-a, TNFRI changes its trimeric conformation allowing an 
adaptor protein named TRADD (for TNFR-associated death domain) to bind through its 
own DD to the clustered DD of the receptor (Hsu et ai, 1995). 
TRADD protein is similar to the already described F ADD, but it does not carry a DED, so 
this protein doesn t seems to be the direct bridge to the activation of caspases. 
Nevertheless, the TRADD DD has an obligate role in TNF-a induced cell death. This 
apparent discrepancy had been resolved by the finding that TRADD functions as a platform 
adapter that recruits several signalling molecules via protein-protein interaction domains, 
such as DD. Among these signalling molecules is FADD/Mortl (Hsu et ai, 1996a). Once 
coupled to the TNFRlITRADD complex, FADD can directly activate pro-caspase-8, 
promoting its self-cleavage and ensuing activation of the effector caspase cascade. The 
mouse model has again proved to be a precious tool to highlight the necessary role of 
F ADD in the apoptotic response stimulated by TNF-a, since cells from F ADD KO mice 
are resistant to the treatment with the cytokine (Zhang et ai, t 998). 
These findings show that FAS and TNFRI use FADD as a common signal intermediate and 
that both of them are able to get access, albeit through slightly different intermediates, to 
the same, evolutionary conserved, downstream apoptotic signalling machinery. 
Unlike CD95, whose signal transduction seems to be restricted to activation of pro-
apoptosis proteins, TNFR I is also able to recruit other proteins such as RIP and TRAF, 
always via TRADD intermediation, which activate not only apoptotic but also protective 
pathways. 
RIP protein is a serine/threonine kinase that is able to preferentially bind TRADD via a DD 
(Hsu et ai, 1996b). This protein may trigger a second apoptotic pathway starting from 
TNFR 1: when over-expressed RIP is able to induce apoptosis, but its signal transduction is 
not entirely clear. The RIP DD is indeed responsible for the propagation of the death signal, 
while the kinase domain has no apparent role. Moreover RIP doesn t possess a DED, and 
this suggests that it recruits some other effector proteins, still unknown. A likely candidate, 
RAIDD (RIP-associated Ich lICED-3 homologous to a Death Domain), has been identified. 
RAIDD is able to interact with RIP through a DD and to recruit caspase2 to RIP (Duan 
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and Dixit, 1997). However its involvement in TNF-Rl triggered apoptosis has not yet been 
clarified. 
RIP is also able to function as a scaffolding protein for the binding of members of the 
TRAF (TNFR-Associated Factor) family (Rothe et ai, 1994). Activation of these proteins 
is crucial for the switching on of the signalling pathway leading to the Nf-kB, a key 
transcription factor, which has a crucial role in triggering the expression of anti-apoptotic 
proteins. Blockade of NF-kB activation through a dominant negative TRAF-2 mutant 
potentiates the cytotoxic activity of TNF-a, suggesting that NF-kB is critical to the 
expression of protective protein(s) that inhibit TNF-induced cell death (Liu et ai, 1996). 
Nf-kB activation by TRAF is mediated through phosphorylation of the IkB, with 
subsequent degradation by the proteasome complex. NF -kB, released from the IkB 
complex, enters the nucleus, activates various genes carrying the NF-kB response element 
and causes the onset of expression of apoptotic suppressive proteins (Beg and Baltimore, 
1996; Van Antwerp et ai, 1996). The situation, however, seems to be more complicated 
than initially expected. TRAF2 gene KO mice have been shown to display only a slight 
defect in their Nf-kB response to TNF-a (Yeh et ai, 1997). Thus TRAF2 may not be 
essential for in vivo activation of Nf-kB. Alternatively there might be another member of 
the TRAF family that binds to TRADD and compensates for TRAF-2. 
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(kinase) expression of 
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Figure 1.7) Model for TNF-a. triggered apoptosis 
TNF-a. binds to TNFRl and the trimerized receptor recruit TRADD via interactions 
between death domain. The death domain ofTRADD then recruit FADDIMORTl in a 
pathway leading to caspase8 activation, and sub equent ICE protea e ca cade activation, 
which, as in the case for F AS, is able to activate the apoptotic program. 
In parallel, another pathway causes the binding of RIP to TRADD tran ducing an apoptotic 
signal through their death domain. In addition RIP together with TRAF-2 activate the NF-
kB transcription factor, activating a protein ynthe i dependent urvival pathway. 
Adapted from (Nagata, 1997) 
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In conclusion, the conservation of basa l apoptotic machinery fro m the CED3-CE D4-CED9 
system in C. elegans to the highly complex system in mammals (involving the caspase 
family, the Apaf-l system and the always increas ing Bcl-2 fa mil y member) has bee n 
clea rl y show n. The grow ing Bcl-2 fa mily ca n so mehow apprec iate multipl e forms o f 
intrace llular damage and external contact stimuli and integ rate these, sometimes competing 
signals to dec ide the fate of the cell. Other death signals, mainly those resulting fro m death 
receptor ac ti vation, find their way of access to the apoptotic machinery bypass ing the steps 
controlled by Bcl-2 fa mily members (Figure 1.8) 
Pas signalling 
TNF 
MITO 
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Figure 1.8) A summary of apoptosome regulation 
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Two path ways have been lin ked with apoptosome function: a Death Receptor-medi ated 
signal that is mainly independent of Bcl-2 fa mily membe rs and that is able to direc tly 
acti vate the ca spa se cascade. and another one which is mainly ba ed on a mitochondrial 
signalling, able to release Cytoc hrome c, ac ti vate Apaf- I and thereby ac ti vat ing the caspase 
cascade. The two pathways are able to operate a cross-talk: ca pa e-8 activation by Fa and 
TN F-a has bee n reported to be abl e to cut the Bid protein and interact with th e 
mitochondria based pathway, because a Bid fragment can induce the efflu x of Cytochrome 
c into the cytoso l. The balance between Bax, Bcl-x l and other Bcl-2- li ke proteins regulates 
thi s efflu x. 
Adapted from (Cecconi, 1999) 
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The picture of the various interacting partners ofTNFR 1 grows in complexity, however the 
framework of the key events leading to cell death appears now quite well defined and is 
summarized in the Figure 1.7. An important and yet open field of discussion is still 
represented by the modulation of TNF -cx apoptotic signalling by intracellular second 
messenger: of importance. in this context appears the role played by the activation of 
sphingomyelinases with ensuing generation of ceramide lipidic messenger and the role of 
nitric oxide in the regulation of the pathway. 
Investigation of these regulatory pathways has been central to my thesis work: because of 
this I will provide a review of the knowledge about sphingomyelin cycle and of NO in the 
context of cell death, as presented in the next sections. 
Introduction 24 
1.4) THE SPHINGOMYELIN CYCLE: AN INTRODUCTION 
The notion of lipids being primarily inert structural components of cellular membranes 
resisted until the late 1970 s. Because of this, the discovery of the phosphoinositide cycle 
(Berridge MJ, 1984) represented a major breaktrough, pointing for the first time to lipids 
as key players in signal transduction events. 
Phosphatidylinositol 4,5-bisphosphate was recognized to be hydrolyzed by phospholipase 
C (PLC) to release the hydrophilic head group inositol 1,4,5-triphosphate (lP3) from the 
lipid backbone, 1,2-diacylglycerol (DAG). JP3 interacts with an intracellular membrane 
receptor, the JP3 receptor, leading to mobilization of Ca2+ from intracellular stores, whereas 
DAG directly binds to and activates protein kinase C (PKC) initiating a separate signal 
transduction cascade (Nishizuka, 1995). From that time onward other lipidic molecules 
found acceptance as second messengers and intracellular modulators: arachidonic acid 
(Piomelli, 1993), phospholipids (An et ai, 1998), phosphatidic acid (Daniel et ai, 1999) 
and phosphatidylinositol 3,4,5-tris-phosphate (Chao and Olson, 1993). More recently 
another class of lipids has been discovered as important signalling molecules: the 
sphingolipids. 
Lipids of the sphingolipid class contain a long-chain sphingoid base backbone (such as 
sphingosine), an amide-linked, long-chain fatty acid and one of various polar head groups. 
The structure of these head groups defines the various classes of sphingolipid subtypes, 
with a hydroxyl group found in ceramide, phosphorylcholine in SM and carbohydrates in 
glycosphingolipids. 
Richard Kolesnick and Yussuf Hannun s groups were the first to point attention to SM-
based signalling pathways. The former group showed in 1987 the rapid activation of 
sphingomyelinases in response to 1,2 diacylglycerol, but not of phorbol ester treatment 
(Kolesnick, 1987) and proposed the existence of a SMase-based signalling pathway 
(Kolesnick, 1989); the latter group showed that this pathway could be activated by 
receptor-mediated mechanisms, and provided the first evidence for ceramide as a second 
messenger (Okazaki et ai, 1990). 
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1.4.1) Enzymes in the sphingomyelin cycle 
The sphingomyelin cycle is initiated upon activation of sphingomyelinases, specialized 
enzymes with phospholipase C activity that hydrolyze the phosphodiester bond of SM, 
causing the cleavage of a complex sphingolipid to ceramide and phosphorylcholine. The 
catabolic metabolism of ceramide proceeds through the action of ceramidase (CDases) with 
the formation of sphingosine, a sphingoid base that serves as substrate for sphingosine 
kinases to form sphingosine-I-phosphate, or that can be recycled into ceramide and 
complex sphingolipids through the action of ceramide synthases (Figure and Hannun et 
ai, 2001). Ceramide can also be the starting point to generate back sphingomyelin. This 
occurs at the Golgi complex through the activity of sphingomyelin synthase, thus 
completing the sphingomyelin cycle, which, in conclusion, appears to be a very complex 
and regulated metabolic pathway. 
In order to generate ceramide this de-novo synthesis pathway requires the coordinate action 
of serine-palmitoyl transferase and ceramide synthase. The reaction starts with a 
condensation reaction, which forms ketosphinganine from serine and palmitoyl-CoA: the 
rest of the pathway schematized in the following figure (Figure 1.9). 
Alternatively, this pathway may re-utilize for ceramide synthesis the sphingosine released 
by sequential degradation of more complex sphingolipids. This pathway can be stimulated 
by chemotherapeutic drugs (daunorubicin, doxorubicin and many others) and ionizing 
radiations and appears to be activated hours after cell stimulation, resulting in a prolonged 
ceramide production . Because of this, it is unlikely to play a role in the early events of 
stress signalling (Mathias et ai, 1998). 
The SM pathway seems to be ubiquitous and evolutionary conserved. Most mammalian 
cells appear capable of signalling through the SM pathway. Receptors as diverse as those 
for CD28, CD95, TNF -a, 11-1 p, progesteron and glucocorticoid signal via the 
sphingomyelin pathway following activation by thei~ respective ligands (Spiegel and 
Kolesnick, t 996). 
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Figure t .9) Sphingolipids structures and enzymes of metaboli m 
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In terms of functional relevance, ceramide has been proposed to act as a coordinator of the 
response to various stresses inducing conditions (Hannun, 1996): this paradigm has been 
supported by the repeated finding that many inducers of stress response (not only those 
inducing apoptosis) result in transient or long-lasting ceramide accumulation, generated 
either by the activation of SMases (Andrieu-Abade et ai, 2001) or the de-novo pathway 
(Perry, 2001), with possible involvement also of the ceramide clearing pathways (SM-
synthase or CDases). 
Attention will be mostly pointed to SMase since they are the central enzymes of SM cycle 
and are rapidly activated by stress stimuli (Wiegmann et ai, 1994; Cifone et ai, 1995). For 
this reason SMase are considered the principal players for the early production of ceramide 
in signalling events. Several isoforms of SMase have been reported, that can be 
distinguished mostly by their different optimum pH of activation. Some, but not all of these 
molecules have been identified at the molecular level. Among these particularly relevant 
appear Neutral SMase (N-SMase) and Acidic SMase (A-SMase) because they are rapidly 
activated by diverse stress stimuli, among which cytokines (TNF-a, Fas) and 
environmental stress (UV radiation, hypoxia). Moreover, their activity promotes an increase 
in cellular ceramide levels over a period ranging from minutes to hours, depending on the 
stimuli and on state of activation of the various enzyme of the cycle (Hannun 1996; 
Hannun et ai, 20ot; Mathias et ai, 1998). 
Human and murine Acid-SMase (pH optimum 4.5-5.0) have been cloned and determined to 
be the product of a single conserved gene: A-SMase was originally considered a strictly 
lysosomal enzyme because of its optimum pH at 4.5-5.0. However, another A-SMase 
isoform has been recently shown to localize to secretory vesicles near the plasma 
membrane (Grassme et ai, 2001) and to be secreted extra-cellularly (Schissel et ai, 1998). 
Other authors have reported the localisation of A-SMase in caveolae at the plasma 
membrane, which are micro-domains enriched in SM. In this compartment SMase can be 
activated by IL-l ~ (Liu and Anderson, 1995). Relevance for cellular homeostasis of A-
SMase comes once again from genetic studies: lack of a functional A-SMase gene has been 
shown to be the cause of a rare lipidic storage genetic dysfunction, the type A and B 
Niemann-Pick disease. 
Niemann-Pick group of diseases has been infact subclassified in two categories, those with 
a primary deficiency in A-SMase activity (types A and B), and those with defective 
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intracellular processing and transport of low density lipoprotein (LDL)-derived cholesterol 
(type C): type A NPD patient suffers of progressive neurodegeneration during infancy, 
while nervous system involvement in type B is linked to the appearance of a cherry-red 
macula. In the two types of the A-SMase-linked NPD, the in-vitro assay for A-SMase have 
shown marked differences, with type-B derived cultured cells showing a significantly 
higher SM hydrolysis than type A. Moreover, also the brain lipid profile of Type A and 
Type B patients differs, with an increase of lysosphingomyelin, believed to be toxic to the 
nervous system, in type A patient versus type B patient (Rodriguez-Lafrasse et ai, 1999). 
This property may account for the milder phenotype of Type B (for a more complete review 
ofNPD diseases refer to Kolodny, 2000). 
KO mice for A-SMase have confirmed its obligatory role for the phenotypes observed in 
the Niemann-Pick disease and, of importance, also for the dysfunctions at cellular level, 
both in the disease and its KO model. These dysfunctions include unresponsiveness, or 
limited response, to apoptosis triggered by a variety of stimuli, including UV radiation and 
TNF-a (Lozano et ai, 2001). 
N -SMases have their optimum pH of activation at 7.4 and are beginning now to be defined 
at the molecular level although the recent cloning by the Stoeffel s group has been 
questioned (Hannun et ai, 2001; Buccoliero and Futerman, in press). Various different 
forms of neutral sphingomyelinases (pH optimum 7.5-8) have been reported, differing in 
their dependence on Mg2+ (Levade and Jaffrezou, 1999). What it is clear, from the 
residual activity of A-SMase KO mice, is that the neutral enzyme(s) results from one or 
more distinct genes, other than that of A-SMase (Horinouchi et al 1995). Knowledge of 
the role of these enzymes is however still confused. In terms of activity it is important to 
note that N-SMase activity has been found to depend on the redox state of the cells and in 
particular on their levels of glutathione. The activity has been found to be de-repressed 
under conditions of oxidative stress, when glutathione is depleted, a condition that appears 
to happen after hours of stress inducing treatment, s,:!ch as TNF -a treatment (Liu et ai, 
1998). 
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1.4.2) Ceramide and cell death 
Evidence supporting ceramide as a messenger molecule in the context of cell death 
emerged from several independent studies (reviewed in Mathias et ai, 1998; Hannun et ai, 
2001) and can be summarised as follows: 
i) In many cellular systems stress-induced increases in ceramide levels, classically 
measured by the diacylglycerol-kinase assay, precede biochemical and 
morphological features of apoptosis. 
ii) Increasing cellular ceramide levels by addition of natural ceramide, exogenous 
SMase or pharmacological agents that are able to interfere with the enzymes of 
ceramide metabolism are able to induce in the cell apoptotic features. 
iii) Genetic models, including Niemann-Pick disease cells, A-SMase knock out 
mice and glucosylceramide synthase knock out mice, display abnormalities in 
several aspects of cell death. 
The observation that other sphingolipids molecules have not been reported to produce 
cytotoxic effects support the notion that ceramide has a central role in modulating and, in 
certain cases, in inducing some forms of stress-associated apoptosis. If the majority of the 
effects that have been described for ceramide imply its action as and be anti-proliferative 
and pro-apoptotic agent, an important class of molecules directly produced by ceramide 
catabolism, sphingosine-I-phosphate (S I P), has been implicated as a second messenger in 
cellular proliferation and survival (Olivera and Spiegel, 1993). Based on this information 
Spiegel and co-workers proposed the ceramide/sphingosine rheostat as a mechanism 
working to coordinately regulate proliferation and apoptosis through sphingolipids 
(Cuvillier et ai, 1996). This model suggests that the fine regulation of the diverse enzymes 
of the SM cycle might be operational in the regulation of the various stress-induced 
apoptoses. 
The recent discovery of a cell surface set of SIP receptors, the EDG proteins, adds a new 
molecular player in this signalling, suggesting that SIP might act not only intracellularly 
but also through a paracrine/autocrine action (Hla et ai, 2001). This fascinating model and 
its operating mode await definitive confirmation. 
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Ceramide has been proposed to trigger the apoptotic pathway via two reported mechanisms: 
one involving the transcriptional activation of the JNK cascade and the other involving 
mitochondrial regulation. 
JNK pathway, which is activated in response to several stress-inducing cytokines, UV, 
ionizing radiation and serum deprivation, lead to the phosphorylation of various 
transcription factors including c-Jun, with activation of transcription factor-2 (ATF -2) and 
CHOP/GADD 153 (Fanger et ai, 1997). The role of ceramide in activating this pathway 
has been demonstrated in several studies. In fact, exposure of bovine endothelial aortic cells 
(BAEC) and monocytic cell line U937 to environmental stresses resulted in rapid ceramide 
generation, activation of JNK pathway and apoptosis (Verheij et ai, 1996). Similarly, 
ceramide analogues stimulated JNK activation while disruption of the pathway with 
dominant-negative mutants of SEK-I or c-Jun blocked TNF-a, stress- and ceramide-
induced apoptosis. Ceramide generation may lead to JNK activation by at least two 
mechanisms: either via transforming-growth-factor ~-activated kinase (T AKI) or via the 
small G-protein Rac-I. Shirakabe et al reported in fact that T AK I is activated in response 
to ceramide or stress leading to ceramide generation, and that a kinase negative TAKI 
blocked ceramide-induced JNK activation (Shirakabe et ai, 1997). Gulbins and co-
workers, on the other hand, showed that in Jurkat cells CD95 activation or ceramide 
treatment resulted in sequential activation of Ras, Rac-l and the JNK pathway (Brenner et 
ai, 1997), while ceramide and Fas have been indicated to activate phosphoinositide-3-
kinase (Pi3-K) also in Jurkat and T cells (Gulbins et ai, 1998). Thus, in response to stress 
stimuli, ceramide may utilize a variety of signalling relays to activate the JNK pathway (a 
pathway which is not only linked to cell death induction but also to effects unrelated to 
apoptosis) or even provide anti-apoptotic protection to the cells (Liu et ai, 1996). This 
contradiction may be only apparent, being due to different actions of various JNK isoforms. 
In view of this, and until better reagents are available to distinguish between the various 
JNK isoforms, it is not possible to define unambiguously the role played by this ceramide-
induced system in apoptosis induction. 
Mitochondria have been shown to have a prominent role in the commitment phase of the 
apoptotic response and to represent a potential target for ceramide action. As described in 
the preceding section, mitochondria may function in the context of apoptotic cell demise 
through release of cyt-c, Apaf-l and the generation of reactive oxygen species (ROS). 8cl-2 
family members regulate signalling of the apoptotic responses through mitochondria in 
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many instances. Several reports show that Bcl-2 is able to inhibit ceramide-induced 
apoptosis, thereby suggesting a mitochondrial action of the lipidic messenger (Farschon et 
ai, 1997; Martin et ai, 1995). 
Two distinct mitochondrial events have now known to be related to ceramide action: 
permeability transition and ROS generation. Even if it is a questioned point, induction of 
apoptosis has been frequently linked to the activation of MTPT, associated with the 
opening of large pores in the mitochondrial inner membrane with ensuing free diffusion of 
small molecules. In isolated mitochondria this phenomenon has been shown to be induced 
by a cytoplasmic fraction isolated from ceramide treated cells (Pastorino et ai, 1996). 
From several studies this effect appears to be trascriptionally-independent (Decaudin et ai, 
1997; Castedo et ai, 1996), stimulated by BAD and by signalled through a ceramide 
activated protein kinase (CAPK; Basu et ai, 1998). 
Also in isolated mitochondria ceramide has been shown to cause ROS formation, most 
likely through inhibition of the respiratory complex Ill. In fact inhibition of electron 
transport through complex 11 and I blocked, whereas inhibition of complex III potentiated 
the ceramide action. Further, TNF-a treatment was shown in one study to increase the level 
of ceramide in mitochondria, suggesting this event to be of physiological relevance 
(Garcia-Ruiz et aI, 1997). 
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1.4.3) Death receptors and sphingomyelinases 
Death receptors, in particular TNF-R55 of TNF-a, have been reported to induce activation 
of both A-SMase and N-SMase, with concomitant generation of bioactive ceramide. Most 
of the data were collected by studies with mutants of the receptor cytoplasmic domain, 
which suggested the existence of a link between receptor activation and SMase activation. 
The results are schematized in Figure 1.10. 
A small motif of 11 aminoacids in the cytoplasmic portion of the TNF-R55 was found to be 
both necessary and sufficient for N-SMase activation (Adam et ai, 1996). This motif, 
termed NSD, was shown to specifically bind a novel WO-repeat protein, FAN, that 
functionally couples TNF-RI to N-SMase (Adam-Klages et ai, 1996). 
In contrast, the activation of A-SMase is due to a region at the C-terminus of the receptor 
corresponding to its death domain (Wiegmann et ai, 1994), which serves as the binding 
domain for TRADD. The latter in turn is able to recruit other proteins, such as TRAF2, 
FADD and RIP. Over-expression ofTRADD and FADD enhance TNF-a induced A-SMase 
activation, while neither TRAF2 nor RIP affects A-SMase activation (Kolesnick and 
Kronke, 1998). 
Taken together, these observations suggest that the SMases are activated through distinct 
molecular mechanism and that this may affect distinct biological processes. With regard to 
programmed cell death, the activation of A-SMase through the death domain adaptor 
system indicates that A-SMase, rather than N-SMase, is involved in TNF-mediated 
apoptotic response. Deletion of the death domain region of TNF-R55 (Wiegmann et ai, 
1994) and CD95 (Cifone et ai, 1995) blocked ligand-induced ceramide generation and the 
ensuing apoptosis 
Evidence for a role of A-SMase in initiating the apoptotic response was provided also by 
genetic models of acidic SMase deficiency. Studies from the Kolesnick s group reported 
that lymphoblasts from patients with Niemann-Pick disease (NPD) and from acidic 
sphingomyelinase knock out mice show defects in apoptotic response (Santana et ai, 
1996;Lozano et ai, 2001). 
At the moment, the role of N-SMase is still much debated, however lack of appropriate 
reagents to investigate its role has made it difficult to interpret with certainty the results so 
far obtained. 
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Figure 1.10) Proposed mec hani sm for TNF-a triggered act ivation ofSMases 
Di fferent intrace llular relays connectin g TNF-R I to di ffere nt SMases isoforms : a 
membrane proximal region of the cytop lasmic domain links the adaptor protein FAN to N-
SMase, while the assembly of a death domain adaptor protein complex links to A-SMase 
activat ion . Poss ible targets of A-S Mase triggered ceramide formation have been depicted, 
with also some reported inhibitors of those effects, such as Bcl-2 on mithoco ndri al 
ce ram ide site of action. A-SMase has also been reported to be direct ly act ivated by 
environmental stresses, such as UV, X-Ray irradiation and heat. 
Adapted from (Kolesnick and Kronke, 1998) 
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If the molecular intermediates between death receptor and SMase activation have been 
defined, at least in part, much of the transmembrane signalling system remains unknown: 
studies from our laboratory suggest that ceramide has a novel role in proximal events of cell 
death receptors activation (DeNadai et aI, 2000). In particular, we produced evidence that 
exogenous ceramide is able to potentiate early TNF-a signalling, namely TRADD 
recruitment to TNF-R55 and caspase 8 activation, with ensuing enhanced apoptotic demise 
of the cells, evaluated by the DNA fragmentation index. This body of evidence will be 
described later on, after having reviewed the present knowledge about NO, in particular, the 
role of NO in the context of cell death. This because in the same work NO was been found 
to inhibit the effect of ceramide on early TNF -u signalling. 
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1.5) NITRIC OXIDE 
The gaseous second messenger nitric oxide (NO) takes part in fundamental physiological 
processes, ranging from cardiovascular function to memory (Dawson et ai, 1992; Feldman 
et ai, 1993; Ignarro, 1989; Moncada et ai, 1991) and to events correlated to microbicidal 
and tumoricidal responses (Hibb, 1991; MacMicking et ai, 1997). An excessive and 
unregulated synthesis of NO, however, has been implicated as a causal or contributing 
factor in many pathological conditions, including vascular shock, stroke, neurodegeneration 
and chronic inflammation (Gross and Wolin, 1995, Wink et ai, 1998). Due to its peculiar 
chemical nature, NO acts via a wide range of biological reactions, not restricted to binding 
to a few specific receptor molecules: it is a small, relatively stable, free radical gas able to 
readily diffuse into the cells and to react with its molecular targets. In this following 
sections I will introduce the generalities of NO, followed by role of NO in cell death, the 
specific subject of my thesis work. 
1.5.1) Nitric Oxide: an historical perspective 
NO has been known since the late 1970 s to be among the ligands able to activate soluble 
guanylate-cyclase (Arnold et ai, 1977) and to cause vascular muscle relaxation via the 
synthesis of cGMP. The gas induces a transient, concentration-dependent relaxation of 
isolated strips of bovine coronary artery (Gruetter et ai, 1979). In parallel, it was shown 
the existence of a factor produced by the endothelium, which had an obligatory role for the 
relaxation of arterial smooth muscle cells induced by acetylcholine administration 
(Furchgott and Zawadzki 1980). This factor was named the endothelium derived 
relaxation factor (EDRF). 
The classical works by Furchgott, Ignarro (reviewed in Furchgott , 1988) and Moncada 
(Palmer et ai, 1987) lead to the identification of NO as ERDF, and triggered an avalanche 
of independent studies carried out in many diverse directions by hundreds of different 
investigators, that unraveled the role of this small molecule in the context of various 
biological processes, starting from the observation that tumour cells can be killed by an L-
arginine dependent activity exerted in activated rodent macrophages (Hibbs et ai, 1987) 
and that the cytotoxic agent responsible for this activity was indeed NO (Stuehr and 
Nathan, 1989). 
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Another area in which a physiological role for NO was independently discovered was 
neuronal signalling in response to NMDA receptor activation: Garthwaite and co-workers 
established that cGMP levels increase in cerebellar granule cells in response to glutamate 
binding to NMDA receptor, and demonstrated the release of a guanylyl cyclase-activating 
factor with biological activity and stability characteristics similar to those of NO/ERDF 
(Garthwaite et ai, 1988). 
1.5.2) Nitric Oxide Synthases: isolation and classification 
Following the characterisation by the Moncada s group of the enzymatic pathway leading 
to generation of NO from L-arginine (Palmer et ai, 1988), a big effort was addressed to the 
identification of the enzyme molecules responsible for the synthesis of NO. Bredt and 
Snyder were the first to purify from the rat cerebellum an enzyme able to synthesize NO 
from the stoichiometric conversion of L-arginine to citrulline in the presence of Ca2+ and 
calmodulin (Bredt and Snyder, 1990). Thereafter, Bredt and co-workers cloned the 
enzyme (Bredt et ai, 1991) showing that its C-terminal shows a homology (40% 
aminoacidic identity; 60% homology) to NADPH cytochrome P450 reductase, and that 
consensus sequence for NADPH, FAD and FMN binding sites are present within this 
enzyme, called neuronal Nitric Oxide Synthase (nNOS). 
The two other known isoforms of NOS where then identified based on degenerate 
nucleotide probes from bovine aortic cells (Sessa et ai, 1992) and from mouse 
macrophages (Xie et ai, 1992). 
Nomenclature of these enzymes has been a matter of debate. The most widely accepted 
identifies the three enzymes from the tissue employed first for cDNA isolation and cloning: 
i) nNOS was originally purified and cloned from the eNS, but now is known to 
have a more wide distribution, with an important level of expression in skeletal 
muscle. This isoform is also named NOS I 
ii) inducible-NOS (iNOS) was originally purified and cloned from an 
immunoactivated macrophage cell line. Since then it has been identified in 
mammals cells as diverse as cardiac myocytes, glial cells and vascular smooth 
muscle cells. This enzyme is also named NOS 11. 
Introduction 37 
iii) Endothelial-NOS (eNOS, also named NOS Ill), the last of three mammalian 
isoforms to be identified, was originally purified and cloned from vascular 
endothelium. Since then it was discovered in various other cell types: e.g. 
cardiac myocytes, blood platelets, hippocampal neurons and T -lymphocytes. 
Although the sequences of the various NOS isoforms are highly conserved across species 
(from 80 to 94% identity), between any two isoforms identity is only 50-60% (Sessa 1994). 
Remarkably, the regions of high homology are associated with the cofactor binding sites, 
strongly pointing to a conservation of the structure-function relationship in this area in the 
codi fied proteins. The NOS proteins contain also a haem and its putative binding site is 
localized to the N-terminal region (Klatt et aI, 1992). nNOS is characterised by the 
presence of a N-terminal region longer than that of the other isoforms, containing protein-
protein interaction domains (such as PDZ domains) which are crucial for its binding to 
other proteins (see next section) 
The sequence homology between the C-terminal half of NOS and cytochrome P450 
reductase, and the presumptive requirement of a haem binding site in the N-terminal 
portion of NOS suggested that NOS is composed ofa distinct reductase (C-terminal) and an 
oxygenase (N-terminal) domains. This feature was found to be crucial for the catalytic 
properties of the enzymes (Figure 1.11) 
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Figure 1.11 ) Relationship among the polypeptide sequence for NOS isoforms and 
cytochrome P450 reductase 
The consensus sequences for the binding of the various cofactors to the NOS isoforms are 
labe ll ed: NADPH (Ade: adeni ne; Ribo: ribose); FAD (ISO : isoalloxazine; Ppi: 
pyrophosphate); FMN and CaM (calmodu lin). The darkened N-terminal region shows 65-
71 % sequence identity between the three isoforms and conta ins the putative L-arginine-
binding region and the binding site for tetrahydrobiopterin and haeme. The gap in iNOS 
sequence represents a 40 aminoacid deletion . 
Adapted from (Griffith and St her, 1995) 
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1.5.3) NOS: catalytic mechanism 
Generation of NO by the three different NOS occurs via a common, similar catalyti c 
scheme, invo lving the tive electron oxidation of the te1111inal guanido nitrogen of L-arginine 
to form NO plus L-c itrulline. Such react ion is compl ex, invol ving mol ecular oxygen and 
N ADPH as co-substrates, with the concomitant presence of numerous other redox co factors 
including the enzyme-bound haem, reduced thiols, FAD, FMN and tetrahydrobiopterin . 
COOH COOH I I COOH 
NHl-C-H NH I-C-H I 
I I NH I - C-H 
CH 2 CHI O.S NADPH 0 . 5 NADP' I I NADPH NADP' fH 2 I H · CH 2 H' CH 2 + NO I I CHI CH, CH2 'Ol H;O I I - O2 H2O I rH2 NH NH I I NH 
C-NH I 
I C= N-OH c-·o 
NH I I NH2 NHl 
L-Arginine NOH-ARG L-Citrulline 
Figure 1.12) Schematic representation of NOS reaction sequence 
The reaction sequence show n in the above equat ion (adapted from Criffith and St ehr, 
1995) represents two successive mono-oxygenase reactions, both being mi xed functions 
oxidations in which the four elect rons necessary to reduce O2 are deri ved from both 
NADPH and the aminoac id substrate. In the first reaction, two electrons are contributed by 
NADPH , and a guanidino nitrogen of arg inine undergoes a two electron oxidation, with 
formation of the enzyme bound NOH-arginine (NOH-ARG) intermediate. In the second, 
one electron is contributed by NADPH, and NOH-arginine undergoes a three electron 
oxidation to tinally form citrulline and NO. The deta il s of nitric oxide synthase activity are 
not yet completely understood but represent still a matter of debate for biochemi st (for 
complete review see St ehr, 1999). 
In order for this complex reaction to proceed, the reductase and the oxygenase domains of 
NOS have to be positioned in a well-defined, three-dimensiona l organi sation , with 
Introduction 40 
calmodulin being a critical player in the process. The consensus sequence for calmodulin 
binding is near the center of NOS, separating the above-mentioned domains: Abu-Soud and 
Stuher argued that the calmodulin binding domain acts a bridge between the reductase and 
the oxygenase domain, and that the binding of calmodulin represents a sort of switch for the 
activity of the enzymes (Abu-Soud and St ehr, 1993). When Ca2 +/calmodulin is not 
bound to the protein, the domains are not aligned and the reductase domain cannot supply 
electrons to haem. Instead, when Ca2+/calmodulin is bound, the domains align and the 
enzyme is fully active (Figure 13) 
For all three NOS isoforms, NO synthesis depends upon the enzyme binding of calmodulin. 
For eNOS and nNOS increases of intracellular Ca2+ concentration ([Ca2+]i) are required for 
calmodulin binding and, consequentely, for enzyme full activation. By contrast iNOS 
appears able to bind calmodulin, and hence become fully activated, even at the low [Ca2+]i 
characteristic of the resting cells. This feature gives rise to a profound biochemical 
difference between the three different isoforms, also reflected by their functional biological 
properties. Intracellular activity of eNOS and nNOS is precisely and closely regulated by 
transient changes in [Ca2+]i, whereas the activity of iNOS in immunoactivated cells is 
dependent on its onset of expression and does not depend on [Ca2+]i transients (Nathan and 
Xie, 1994). 
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Figure 1.13) Centra l role of ca lmodulin (CaM) in NOS act ivity 
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This sc hematic model highli ghts the key role of CaM in aligning the oxygenase (N-
terminal) and reductase (C-term inal) domains of NOS. The black arrow indicate the 
direc tion of the electron now. CaM with four assoc iated Ca2+ atoms binds to a region in the 
middle of the two domains and, so doing, it is ab le to align them and allow electron transfer 
from FMN to haem. In the absence of arginine, molecular oxygen (0-0) can dissociate 
from haem as superoxide (02-) 
Adapted from (Griffith and St ehr, 1995) 
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1.5.4) NOS: sub-cellular localization and function 
Another important feature of NOS enzymes is represented by their subcellular localization, 
since localization within the cell might be expected to influence the biological role and 
chemical fate of produced NO. 
Of the three isoforms, iNOS and nNOS have been reported to be soluble (cytosolic), while 
eNOS have been found to be primarily localized at particulate sub-cellular fractions, such 
as plasma membrane and Golgi fractions (Hecker et aI, 1994; Sessa et aI, 1995). 
This distinction is not so clear-cut since important protein-protein interactions have been 
reported also for nNOS and iNOS that may have an important role also in their localization. 
The N-terminal domain of nNOS contains a PDZ domain, a protein-protein interaction 
sequence, which scaffolds the enzyme to integral membrane and cytoskeletal proteins of 
skeletal muscle, such as the dystrophin complex (Brenman et ai, 1995) and a.-I syntropin, 
and neurones (PSD95, see Brenman et aI, 1996). Another protein target for PDZ domain 
interactions with nNOS has been identified as the muscle isoform of phosphofructokinase 
(PFK-M) in skeletal muscle and neurons (Firestein & Bredt, 1999). The functional 
importance of these interactions is still under investigation. 
Using an iNOS-GAL-4 DNA binding domain fusion as a bait to screen a GAL4 activation 
domain-tagged, mouse kidney cDNA library by the two-hybrid method, the group of Kone 
has identified an interaction between iNOS and the Rho family GTPase Rac2 (Kone and 
Kuncewiicz, 1998). Functional studies have indicated that such interaction may be 
important in regulating iNOS activity. The authors propose that Rac2 serves as an allosteric 
activator of iN OS in macrophages. 
The most complete body of information is referred to eNOS, originally described as a 
protein localized in discrete subcellular localization. eNOS does not contain any 
hydrophobic transmembrane domain, and its plasma membrane localization is mediated by 
acylation. In fact, eNOS is co-translationally and irreversibly myristoylated at an N-
terminal glycine residue while palmitoylation occurs post-translationally, and reversibly, at 
cysteine residue Cys 15 and Cys26. These modifications have been clearly demonstrated to be 
crucial for eNOS targeting to plasma membrane and to Golgi region. More precisely, 
myristoylation targets the protein to the Golgi apparatus where it is palmitoylated. The 
double acylated protein is then targeted to the plasma membrane, where it colocalizes with 
the resident integral membrane protein of caveolae, caveolin-l (Shaul, 2002). 
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Localization of eNOS appears to be an important feature for enzyme regulation. In the 
plasma membrane rafts, caveolin-l has been reported to interact with eNOS by a direct 
protein-protein interaction (Li et aI, t 996), thus inhibiting the eNOS activity both in vitro 
and in endothelial cells (Garcia-Cardena et aI, t 997; Michel et aI, 1997). 
The interaction ofcalmodulin and/or caveolin-l with eNOS has been shown to be mutually 
exclusive, suggesting a dynamic regulation of the enzyme by [Ca2+k At rest eNOS is 
tethered to caveolin-l and inactive. After [Ca2+]i increase, calmodulin binds to and caveolin 
dissociates from eNOS resulting in an activated eNOS/calmodulin complex. When the 
[Ca2+]i wave subsides, the cycle is reversed, with calmodulin dissociating and caveolin re-
associating with the now inactive eNOS (Michel et al t 997). This regulation of activity by 
caveolin-l may have implications relevant also to pathological situations: for example, 
serum from hypercholesterolaemic patients increases the expression of caveolin-l and the 
formation of caveolin-eNOS heterocomplex in endothelial cells, thereby limiting both the 
basal and the agonist stimulated NO release (Feron et aI, t 999). This may represent a 
rationale for the endothelial disfunction in hypercholesterolaemia. 
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1.5.5) NOS: modulation of activity through phosphorylation 
Another important post-translational modification of eNOS is phosphorylation, which has 
been found to regulate enzyme activity. This is of particular interest as it would potentially 
represent a means to correlate NOS activity with other signalling pathways other than the 
classical [Ca2+]i rise dependent mechanism. 
Even in this case eNOS represent the most tightly regulated enzyme. In fact it has been 
clearly shown that fluid shear stress elicits phosphorylation and activation of eNOS 
(Corson et ai, 1996). Further studies have shown that eNOS phosphorylation occurs on 
Serl 1l79, by serine/threonine AKT kinase (Dimmeler et ai, 1999; Fulton et ai, 1999). The 
mechanism underlying this Ca2+ -independent activation of the enzyme is still unknown. 
The proposed mechanism is that the Akt mediates phosphorylation results in an increased 
electron flux through the reductase domain of the enzyme, and thus in increased NO 
production (McCabe et ai, 2000). This activation seems to be Ca2+-independent. This 
definition, however, might be misleading, in the sense that the Ca2+ /CaM complex is 
always necessary to induce NO production. A possible explanation is that phosphorylation 
acts by lowering the level ofCa2+ required to activate the enzyme. 
Other than shear stress, a variety of stimuli as diverse as estrogen (Haynes et ai, 2000), 
vascular endothelial growth factor (VEGF, Fleming et ai, 2001), insulin (Montagnani et 
ai, 2001) and sphingosine-I-phosphate (Igarashi et ai, 2001) have been linked to eNOS 
activation through activation of Pi3K/AKT. Other phosphorylation sites and protein 
interactions have been proposed to be important. In these cases, however, the framework is 
still quite confused, and further investigation is necessary to have the final picture (see 
Fulton 2001 for a review). 
Modulation through phosphorylation has been also indicated for nNOS: in this case the 
Ser847 phosphorylation operated by CAM Kinase 11 has been linked to a decrease in NOS 
activity (Hayashi et ai, 1999). No report to date, instead, has linked iNOS regulation to 
phosphorylation of relevant sites. 
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1.6) NITRIC OXIDE AND CELL DEATH 
NO is an important regulator of cell death, however with intriguing properties. The gas, in 
fact, has been shown to have both detrimental effects on cell viability, as well as protective 
effects in various paradigms of cell death. This bi-univoque behaviour was mainly 
correlated to the source and with the mode of NO production: NOS isoenzyme specific 
activity allowed to discriminate between a low and regulated versus a high and massive 
output of NO production, and to establish a rough correspondence between homeostatic and 
toxic functions of the gaseous messenger. 
1.6.1) NO as a pro-apoptotic agent 
The first reports of detrimental effects, such as lysis of islet cells by activated macrophages 
through an arginine dependent NO generation, came in the early nineties (Kroncke et ai, 
1991). Indications of NO-mediated apoptosis were independently reported by several 
groups in 1993 (Albina et ai, 1993; Sarih et ai, 1993; Xie et ai, 1993); evidence for NO-
induced apoptosis in macrophages was provided by chromatin condensation and inter-
nucleosomal DNA fragmentation, and its involvement was confirmed by preventing these 
features by an L-arginine restricted medium or by the presence of the NOS inhibitor, L-
NMMA. 
In various cells the production of high levels of NO is associated with cytotoxicity: iNOS-
generated NO stimulates apoptosis in ascite hepatoma cells in tumor bearing rats 
(Nishikawa et ai, 1998) and NO causes autolysis in tumor cells and bystander cells (Xie et 
ai, 1997). Furthermore, macrophages from septic shock mice exhibit increased apoptosis 
that was rescued by NOS inhibition (Williams et ai, 1997). A functional role of stimulated 
NO production was also established in T -Cell Receptor (TCR)-triggered apoptotic death of 
mature T -lymphocytes (Williams et aI, 1997). 
Following these initial observations, an avalanche of reports have confirmed the ability of 
NO to induce cell death in cellular models, as diverse as B-cells, thymocytes, chondrocytes, 
neurons, vascular endothelial cells and other. In all of these cases the detrimental effects 
were related to the iNOS-induced expression and massive chemical production of NO. High 
concentrations of NO were correlated to p53 (the principal cell cycle controller and 
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apoptosis initiator) accumulated at an early time point, preceeding DNA fragmentation. 
Such a p53 accumulation was attenuated by blocking NO production (Brockhaus and 
Br ne, 1999 ). There are indications that the proposed accumulation of p53 by NO is 
sustained by activation of the MAPK signalling pathway (Callsen and Br ne, 1996 ), but 
the exact causal relationships are yet to be clarified. 
Another important player in NO-induced cytotoxicity is represented by Bcl-2 family 
members: in several studies, NO-evoked apoptosis and decreased expression of anti-
apoptotic Bcl-2 family members were correlated, while expression of the pro-apoptotic 
protein Bax was increased during NO-induced apoptosis. Macrophages transfected with 
human Bcl-2 and showed protection against various NO donors and endogenously 
generated NO, although in these cases p53 accumulation remained unaltered. These results 
show that Bcl-2 acts downstream of p53 and upstream of cyt-c release, that was instead 
attenuated (Messmer et ai, 1996; Bonfoco et ai, 1997; Melkova et ai, 1997). 
A key player in apoptosis induction, as already mentioned, is represented by mitochondria. 
Several indications exist in fact of an effect of NO on mitochondrial function, with a fall-
out consequence on cell death. The NO-dependent, macrophage-induced cytotoxicity of 
tumor cells has been associated with characteristic sets of metabolic changes in various cell 
types, in particular inhibition of mitochondrial aconitase, complex I, complex 11 and nuclear 
DNA synthesis. These changes are reproduced by incubating the cells anaerobically with 
NO, suggesting an effect of NO on the iron sulphur centres of mitochondrial enzymes. It is 
not yet completely known whether these effects are ascribed directly to NO, or to its 
derivative peroxynitrite (ONOO.-) (for a complete review, see Brown, 1999). 
Treatment of macrophages with NO donors causes a reversible inhibition of respiration, 
while treatment for several hours induces an irreversible blockade which appears to be due 
to the inhibition of complex I (Clementi et ai, 1998). Remarkably, induction of iNOS 
caused an irreversible inhibition of mitochondrial respiration in a variety of cell types: in 
fibroblasts, interferon-y-dependent induction of iNOS expression caused inhibition of 
respiration by an arginine dependent process (Dijkmans et ai, 1991); in cultured astrocytes 
or microglia, the same expression caused an irreversible inhibition of complex I, which 
could be prevented by NOS inhibitors (Bolanos et ai, 1994). 
The NO-dependent cell damage might be ascribed to various effects of the gas: inhibition 
of respiration, depolarisation of mitochondrial membranes, release to the cytosol of 
mitochondrial apoptogenic factors (such as cyt-c) in the cytosol, cell oxidation and 
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activation of the apoptotic machinery (Hortelano et ai, 1997). The mechanism of the NO-
induced apoptosis appears, however, to depend upon many other conditions accompanying, 
but not due to, NO. ATP levels are crucial for a switch between apoptosis and necrosis, and 
NO has been shown to induce apoptosis or necrosis depending on the [ATP] levels 
(Richter et ai, 1997). The presence of glucose and the rate of glycolysis of each single cell 
can also be crucial to the NO responses, as cells can survive the inhibition of mitochondrial 
respiration caused by induction of iNOS as long as glucose is present and A TP levels are 
mantained (Geng et ai, 1992). 
Also the inhibition by NO of cytc-oxidase might play a role in the cytotoxicity of iNOS-
expressing cells toward bacteria, tumour cells, host cells and iNOS expressing cells 
themselves. iNOS expressing cells in culture can in fact reversibly inhibit various cellular 
respiration by this means. The reversible inhibition might be then turned to an irreversible 
and cytotoxic inhibition by a variety of factors, which might include necrosis caused by 
A TP depletion, opening of the permeability transition pore, and Ca2+ release from the 
mitochondria. 
Pathological situations, mimicked for example by stimuli such as LPS, a potent 
immunostimulator, induce expression of a wide array of genes, as well the release of 
inflammatory cytokines and NO. All these effects have been linked to apoptosis in 
macrophage cell lines and in primary lines (Lakics and Vogel, 1998). 
Indeed, in conclusion, several observations indicate that iNOS induction and apoptosis are 
positively correlated. Moreover, positive correlations exist between NO and important 
pathological conditions such as the development of atherosclerotic lesions (Kinscberf et ai, 
1999), osteoarthritis (Borderie et ai, 1999) and lupus nephritis (Wang et ai, 1997), 
pointing to an importance of iNOS expression and NO synthesis in relevant human 
diseases. 
Despite the intensive work, the exact mechanism(s) by. which NO kills cells is(are) still not 
perfectly clear (see Figure 1.14 for a schematic summary of the current knowledge); 
moreover a large literature shows that NO is also cytoprotective as reviewed in the next 
section. 
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i.e. Macrophages 
NO donors inducible NOS 
Apoptosis 
Figure 1.14) Signaling components characterizing NO-triggered apoptosis 
In this summary sc heme there are indica ted several signalling components on NO mediated 
cell death, as we ll as some possible antagoni stic interventions (grey boxes). It is important 
to note that the arrows don t imply a direct cause-effect relat ionship between the indicated 
components. 
Adapted from (Br ne et aI, t 999) 
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1.6.2) NO as an anti-apoptotic agent 
The first demonstration of protective effects exerted by NO was obtained first in B-
lymphocytes (Mannick et ai, 1994) and later shown in a variety of other cell types 
(reviewed in Liu and Stamler, 1999). Also iNOS-generated NO may be protective. In fact, 
both Epstein-Barr virus (EBV) infected B cells, as well as EBV negative Burkitt s 
lymphoma cell lines, express iNOS constitutively and the inhibition of the basal enzyme 
activity with L-NMMA or by substrate depletion causes an increase in the rate of 
spontaneous apoptosis. This increase of apoptosis was partially blocked by administration 
of L-, but not 0-, arginine. 
NOS not only protect B cells against spontaneous apoptosis but also from apoptosis 
induced by Fas activation (Mannick et ai, 1997); the same is true also for T cells and 
monocytes (Sciorati et ai, 1997; Mannick et ai, (997). Protective effects of NO were also 
demonstrated in hepatocytes, where L-NMMA and L-NAME, but not the iNOS inhibitor L-
N6-(1-iminoethyl)lysine (L-NIL), potentiated LPS-induced necrosis (Ou et ai, 1997). In 
addition, the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) suppressed both 
spontaneous hepatocyte apoptosis and that induced by TNF-a. or anti-Fas antibody in vitro 
(Kim et aI, 1997; Saavedra et aI, 1997). NO donors have also been reported to inhibit 
apoptosis in both human neuroblastoma and rat PC 12 cell lines (Farinelli et ai, 1996; 
Lievremont et aI, 1999; Ogura et aI, 1998). 
Cytoprotection by NO appears of physiological relevance also in the endothelium: it has 
been shown that shear stress, an important trigger of eNOS activity in vivo, protects human 
umbilical venous endothelial cells from apoptosis induced by TNF-a. (Dimmeler et ai, 
1997), oxidative stress (Hermann et ai, 1997) or oxidized LDL (Dimmeler et al,1999). 
The protective role of eNOS-generated NO has been clearly shown also in rat embryonic 
motor neurons, where only eNOS is constitutively expressed (Estevez et ai, 1998). 
Application of L-NAME had no effect but resulted in apoptosis when motor neurons were 
cultured in the presence of brain-derived neurotrophic factor (BDNF). 
Multiple mechanisms, either dependent or independent on cGMP production, have been 
proposed to explain the protective role of NO in the above- mentioned cell systems. Among 
the cGMP independent protective effect, particularly relevant appears the inhibitory S-
nitrosylation of the cysteine catalytic site of caspases, as shown for different classes of NO 
donors as well as for endougenously generated NO. For example, SNAP efficiently S-
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nitrosylates recombinant caspase-3 (Kim et ai, 1997), caspase I and caspase 8 (Dimmeler 
et ai, 1998). 
Nitrosylation is however a very questioned issue in the field, and there is debate as to 
whether the process is real and widespread in vivo, since it seems to require particular 
conditions that seldom occur under physiological conditions. An important prerequisite for 
nitrosylation to occur is that the cell reducing potential (maintained mainly by GSH) is low. 
In the case of the TNF-a triggered death this appears to occur only much later than the 
application of apoptotic stimuli (Higuchi et ai, 1998). 
Another possible protection mechanism by direct action of NO has been suggested to be the 
consequence of reversible inhibition of mitochondrial respiration exerted by nanomolar 
concentration of the gas. In particular, inhibition of respiration at complex IV leads to a sort 
of temporary freezing of the mitochondrial apoptotic machinery, as it stimulates reversal 
of mitochondrial ATPase, with maintainance of the mitochondrial membrane potential 
(8eltran, et ai, 2000). 
cGMP-dependent effects have been clearly shown in some cellular systems. In rat motor 
neurons eNOS protection was shown to be dependent on soluble guanylate cyclase: ODQ, 
an inhibitor of soluble guanylate cyclase, induced apoptosis in cells treated with BDNF. 
Such an effect was relieved only by treatment with cGMP analogues (Estevez et ai, 1998). 
Similar observation has been made in peI2 cells (Farinelli et ai, 1996), hepatocytes (Kim 
et ai, 1997) and ,,(0-T lymphocytes (Sciorati et ai, 1999). The effect of the NO-triggered 
cGMP accumulation may be mediated through cGMP-dependent protein kinase (Kim et ai, 
1997). The precise mechanism of action of this enzyme in apoptosis prevention is however 
still not known. Possible target of the NO/cGMP protective action have been identified at 
the level of the mitochondria: inhibition of cyt-c release (Li et ai, 2000) and collapse of the 
mitochondrial membrane potential (Takuma et ai, 2001). 
Moreover, a cGMP dependent protection could be due to the suppressed expression of the 
protein BNIP3 (Zamora et ai, 2001), a pro-apop.totic protein of the BH3 domain-
containing BCL-2 family (including BIK, BID and BAD), localized to mitochondria and 
other cytoplamic membrane structures (8oyd et ai, 1994). The exact mechanism of BNIP3-
mediated cell damage still remains unknown, but might be due to formation of 
heterodimers with anti-apoptotic proteins (Yasuda et ai, 1998). Since BNIP-3 is a pro-
apoptotic protein, suppression of its expression by NO/cGMP may contribute to the anti-
apoptotic activity of NO. 
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Evidence produced in our lab has shown that in y3-1ymphocytes, the sensitivity to CD95-
induced cell death was progressively acquired, and that this feature was directly correlated 
with the downregulation of eNOS. T cells treated after 14 days of propagation (when eNOS 
is still present) were significantly resistant to CD95 activation. This resistance was relieved 
by the treatment of the cells with haemoglobin (a nitric oxide scavenger), with L-N-
(iminoethyl)-ornithine (L-NIO), a NOS inhibitor, and by pretreatment with the soluble 
guanylate cyclase inhibitor, ODQ. Of importance, in these cells NO/cGMP was able to 
inhibit the first wave of ceramide production, indicating the importance of NO in the 
control of the levels of this pro-apototic lipidic messenger. After 21 and 28 days of 
restimulation, y3-cells lost eNOS expression and acquired sensitivity to CD95 treatment 
(Sciorati et ai, 1999). 
Taken together these results indicate that NO/cGMP generated from endogenous eNOS is 
able to protect from CD95-triggered apoptosis, possibly through a ceramide dependent step. 
The intracellular pathways of this cGMP-dependent action of NO, and its ultimate target, 
remain to be established. 
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1.7) AIMS OF THE THESIS 
A recent paper by our group identified a previously undescribed site of possible regulation 
of apoptotic signalling by NO/cGMP (DeNadai et ai, 2000). In the case of apoptosis 
triggered by TNF-a, cGMP-dependent protection by NO involves inhibition of proximal 
events of the apoptotic cascade triggered by the cytokine, i.e. recruitment to TNFR I of the 
adaptor protein TRADD (Figure 1.15), and ensuing activation of the initiator caspase 8. 
We found that this effect of NO/cGMP was due to the impainnent of the TNF -a-triggered 
generation of pro-apoptotic lipid messenger ceramide, occurring in the first minutes after 
cytokine treatment of the cells (Figure 1.16). We also found that this inhibition correlated 
with the NO/cGMP triggered modulation of DNA fragmentation triggered by the treatment 
with TNF-a. (Figure 1.17) 
This body of data represented an important novel finding, since regulation by intracellular 
messengers of receptor events, never reported previously, might represent a very important 
keypoint of regulation of apoptosis, at a point where even small changes might result in 
substantial downstream consequences. 
• The first aim of the present thesis was to evaluate which might be the target of 
NO/cGMP in the regulation of these proximal events in V937 cells. To answer this 
question we have studied the effect of NO administered via exogenous chemical donor. 
• The other aim of the thesis was to establish and characterize a model to study directly 
the role endogenously produced NO in the modulation of TNF -a-triggered apoptosis. 
To this aim we have engineered a HeLa tet off cell line, in which we could control 
eNOS expression by controlling the concentration of doxycycline in the culture 
medium. This cellular model is particularly useful to directly test the effects of 
regulated expression of eNOS on several biological endpoints in a system that failed to 
express endogenous NOS and to evaluate the direct role of expression of a the enzyme. 
Results obtained have been subdivided in two sections describing experiments carried out 
to fulfil each of the two specific aims outlined above. 
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Figure 1.15) Effects ofceramide, NO, and cGMP on TNF-a-induced TRADD 
recruitment to TNF-R I. 
A) Time course of TRADD recruitment induced by TNF-a(50 ng/ml)/CHX (I )l g/ml) 
revealed by Weste rn blotting of the precipitates with an anti-TRADD Ab. The gel 
shown is representative of four individual experiments: 0, 2, 5, and 10 indicate the 
tim e (min) of cell ex posure to TNF-a before immunoprec ipitation . Thirty 
micrograms of whole-ce ll homogenate was loaded in lane L as an internal control. 
Migration of the Ig heavy chain (HC) and TRApD is spec ified on the right. 
B) Cells were treated with TNF-a (5 0 ng/ml)/CHX ( I )lg/ml) (control) with or without 
SNAP (300 )lM), 8 Br-cGMP (3 mM), ODQ ( I )lM), D609 (25 )lg/ml) and C2 Cer 
(20 )lM) in va rious combinations, as indicated in the key. The spec i fi c bands 
recognized by the anti-TRADD Ab were analyzed by densitometry, and values are 
expressed as a perce ntage of tho e ob erved in the TN F-a/CHX-treated control 
(n =5). 
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Figure 1.16) Effects of NO and cGMP on TNF-a-induced ceramide generation. 
Ce ll s were treated with TNF-a(50 ng/ml)/CHX (I Ilg/ml) (control) with or without SNAP 
(300 IlM), 8 Br-cGMP (3 mM), and ODQ (1 IlM) as indicated in the key. Cell aliquots 
were co llected and lysed, and ceramide content was measured by DAG kinase assay as 
described in (DeNadai et ai, 2000). Ceramide concentrations are expressed as a percentage 
of those measured in ce ll samples run in parallel but not treated with TNF-a/CHX (basal 
value were 140 - 8 pmollmg proteins) (n = 5) . 
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Fig. 1.17) Effects of exogenous ceramide, NO, and cGMP on TNF-a-induced apoptosis . 
U937 Ce ll s were treated with TNF-a (50 ng/ml)/CHX ( 1 Jlg/ml) (control) w ith or without 
SNAP (300 JlM), 8 Br-cGMP (3 mM), and C2 Ccr (20 JlM) for the indicated time points 
before DNA fragmentation ana lysis as indicated in (DcNadai et ai , 2000) 
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Chapter 2 
RESULTS 
Effect of exogenous NO on early signalling by TNF-a in U937 cells 
2.1) Time course of TNF -a-triggered sphingomyelinase activation 
In order to elucidate the enzymatic activity(ies) responsible for the early wave of ceramide 
accumulation in the cell as showed in our previous paper (De Nadai et ai, 2000), I 
measured the activation of both N- and A-SMase in U937 cells at differe.nt time points after 
TNF-a stimulation, taking advantage of the method first described by Wiegmann et ai, 
(1994). This method is based on the measurement of the in vitro conversion of radioactively 
labelled sphingomyelin substrate, as described in the materials and methods section. 
V937 cells were treated with 50 ng/ml TNF -a for the time points indicated in Figure 2.1, 
and the SMase activity of cell lysates was measured at the optimum pH for either enzymes 
(pH 5.5 for A-SMase and pH 7.4 for N-SMase). SMase activity was defined as the 
percentage of radio-labelled sphingomyelin that was converted to its degradation product, 
phosporyl-choline, evaluated as the radioactivity collected in the aqueous phase after the 
separation from organic solvents, and measured by liquid scintillation. 
As shown in Figure 2.1, TNF-a treatment caused a very rapid activation of both SMase, 
that was clearly detected two minutes after treatment, peaked after 5 minutes and then 
levelled off, returning to the baseline values after 15 -30 minutes. 
No further increase of the A-SMase activity was detected during further incubations (Fig 
2.1A), while N-SMase had a second prolonged phas~ of rise, starting after 90 minutes of 
the stimulation with the cytokine and continuing to increase for the rest of the observation 
period (Fig2.1B). The reason for this delayed N-SMase activation is unknown, but a 
possibility is that the fall of GSH levels, reported to happen in these cells after TNF-a 
treatment, has a role in this result (Higuchi et ai, 1998). 
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Figure 2.1) Time course of activation of A-SMase (A) and N-SMase (8) by TNF-(l in 
U937 cells 
Cells were treated with 50 ng/ml TNF-(l and samples were collected at the indicated time 
points. SMase activities were determined in cell lysates by measuring sphingomyelin 
hydrolysis to phosphoryl-choline at pH 5.5 (A) and 7.4 (8). the lysis buffers were specific 
for the pertinent SMase to test (as indicated in the Materials and Method section). 
Values are expressed as % ± s.e.m over basal SMase activity (Values were 21±5 pmollmg 
min- I for A-SMase and 9±4 pmollmg min- I for N-SMase) (n=5) 
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2.2) NO inhibits sphingomyelinases activation 
Since both SMases were found to be activated in the first minutes following TNF-a 
treatment, and since, in our previous paper NO was able to induce protection from TNF-a 
induced apoptosis in these cells in the first minutes following the cytokine administration, I 
decided to analyze the effect of NO on the activation of both SMase induced by TNF-a in 
the peaking activity time window. Specifically, I measured the peak activation of both 
SMases showed on Figure 2.1, that is after five minutes of TNF-a, in the presence of 
increasing concentration of the NO donor SNAP, and I used concentration of SNAP from 0 
to 300 JlM which had no cytotoxic etfect (DeNadai et ai, 2000) 
Results are shown on Figure 2.2A: both A- and N-SMase activation were progressively 
inhibited by increasing concentration of SNAP, albeit with different apparent ICso for the 
two activities: A-SMase responded to a lower concentration of SNAP (apparent ICso 10 
JlM), while N-SMase inhibition required a higher concentration of NO (apparent ICso 45 
JlM). 
I then explored whether this effect of NO was direct, or whether it involved the activation 
of soluble guanylate cyclase and the formation of cGMP. To this end I exposed the cells to 
TNF-a in the presence of the cell permeant cGMP analogue, 8 Br-cGMP (1 mM), and the 
compound BAY 41-2272 (l JlM), which is able to stimulate soluble GC through a NO-
independent site (Stasch et ai, 2001), mimicking its action. Under these conditions the 
increased activities of both SMases following TNF -a treatment were inhibited. 
The inhibition ofsGC by the specific inhibitor H-[l,2,4]oxadiazolo[4,3-a]quinoxalin-l-one 
(ODQ, 1 JlM) (Moncada and Higgs, 1995) was able to reverse the inhibitory effect of 
SNAP (300 JlM) on both A- and N-SMase; the same effect was induced by the pretreatment 
of the cells with the protein kinase G inhibitor, KT5823 (Gadbois et ai, 1992). All these 
effects are displayed on figure 2.28. Basal sphingomyelin hydrolysis was never affected in 
the SMase assay when all these compounds were administered in the absence ofTNF-a. 
Taken together, these results, obtained with various and structurally unrelated 
pharmacological tools, indicate that NO is able to inhibit the TNF-a triggered A-and N-
SMase activation via a mechanism involving the activation of GC, formation of cGMP and 
activation of protein kinase G 
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Figure 2.2 ) NO inhibits TNF-a tri gge red A-S Mase and N -SMase ac ti vities through the 
gene ratio n o f cG M P and the ac ti va ti on of Protein Kina e G 
A) U93 7 ce ll s we re trea ted w ith 5 minutes TNF-a (5 0 ng/ ml ) in the presence of 
increasing concentrations of the exogenous NO do nor, SNAP (0-300 JlM) 
B) Ce ll s were treated for 5 minutes with TNF-a (50 ng/ml) with or w ithout SNAP (300 
JlM), 8Br-cGMP ( I mM), SNAP + ODQ ( IJlM), BAY-4t-2272 ( I JlM) and SNAP 
(300 IlM) + KT5823 ( I JlM). 
In both the pane ls SMase ac ti vities we re measured as desc ribed in Fig 2.1 lege nd and 
ex pressed as % - s .e .m. of the ac ti v iti es measured in the pre e nce of o nl y TN F-a 
(conside red as 100 %: see figure 2. t legend for ab olute va lue ) . Sta ti ti ca l va lue are 
measured vs ce ll s treated w ith TN F-a a lone (n=6) 
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2.3) Contribution of sphingomyelinases to early features of apoptosis 
The contribution of the various forms of SMase activities to apoptosis has been found to 
vary depending on the cell system utilized (see Introduction section and the following refs 
(Perry and Hannun, 1998; Levade and Jaffrezou, 1999; Lozano et ai, 2001; Segui et ai, 
2001). Till now. however. no knowledge is available about the possible role and 
contribution of each enzyme to the early signalling ofTNF-a.. 
2.3a) Specificity of sphingomyelinases inhibitors 
To try to evaluate the specificity problem we used a range of known compounds. namely 
imipramine (Jensen et ai, 1999) tricyclodecan-9-yl xanthate (D609, DeNadai et ai, 2000) 
and monensin (Garcia-Ruiz et ai, 2000), which inhibit A-SMase activity, as well as 
scyphostatine (Tanaka et ai, 1997) and L-camitine (Andrieu-Abadie et ai, 1999), which 
are inhibitors of N-SMase activity. Cells were pre-incubated with these compound for the 
times indicated in the Materials and Method section. 
The specificity of the compounds was checked by assaying SMases at their peak activity, 
i.e. after 5 minutes treatment with TNF-a. (50 ng/ml). At the concentrations used 
imipramine (20 JlM). monensin (1 JlM) and 0609 (25 Jlg/ml) were found to inhibit TNF-a. 
triggered A-SMase, and not N-SMase activity (see Figure 2.3), while scyphostatin (1 JlM) 
and L-camitine (10 Jlg/ml) inhibited N-SMase, and not A-SMase, activity (see figure 2.4) 
triggered by TNF-a.. 
Of importance, when these compounds were administered alone they didn t have any effect 
on the basal conversion of sphingomyelin to ceramide: for A-SMase absolute values were 
imi 19--4 pmol/mg min- I ; mon 18-5 pmol/mg min- I ; D609 20-3 pmol/mg min- I ; L-carn 
22-5 pmol/mg min- I ; scypho 20-2 pmol/mg min- I; for N-SMase absolute values were imi 
9--4 pmol/mg min-I; mon 8-5 pmol/mg min-I; 0609 8-3 pmal/mg min-I; L-carn 9-2 
pmol/mg min- I ; scypho 8-2 pmol/mg min-I. 
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Figure 2.3) Speciticity of action of drugs on A-SMase activity triggered by TNF-a 
U937 ce lls were treated for 5 minutes with T NF-a (50 ng/ml) with or without imipramine 
(imi , 20 IlM), monensin (mon , I IlM), 0609 (25 Ilg/ml) , L-carnitine (L-earn . 10 Ilg/ml) 
and scyphostatin (seypho I IlM) . A-SMase activi ty was measured as described in the Fig 
2. 1 legend and expressed aga in as % - s.e.m. of the activity measured in presence of only 
TN F-a alone (considered as 100%). Absolu te va lues were : untreated cells 21- 5 pmollmg 
min-I ; ce ll s treated with TNF-a 33-4 pmollmg min- I . 
In the present figure I on ly show the va lues obtained by co-incubation of the various 
compound with TNF-a, as the incubat ion with on ly the compounds doe n t result in any 
va riation from untreated ce ll s in tenns of spingomyelin conversion (see text at pag 60 for 
abso lute values) . 
Indicated statistical va lues were measured versus cells treated with TNF-a alone (n=5) 
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Figure 2.4) Specificity of act ion of drugs on N-SMase act ivi ty tri ggered by TNF-a 
U937 ce ll s were treated for 5 minutes w ith TNF-a (50 ng/ml ) with or wi thout imipramine 
(imi , 20 IlM ), monensin (mon , I J.1M), 0 609 (0609 , 25 J.1g/ml), L-carnitine (L-carn . 10 
J.1g/ml) and scyphostatin (scypho I J.1M). A-SMase activ ity was measured as desc ribed in 
the Fig 2 .1 legend and expressed again as % ± s.e .m. of the activity measu red in presence of 
only TNF-a a lo ne (cons idered as 100%). Abso lute va lues were: untreated ce ll s 9±4 
pmol /mg min"; ce ll s treated with TNF-a: 17±3 pmollmg min-'. 
Aga in r o nl y show the co- incubat ion of the various compounds with TNF-a, as the 
incubation with only the drugs doesn t resu lt in any variation from untreated ce lls (see text 
at page 60 for abso lute va lues). 
Indicated statistica l va lues were measured versus cell s treated w ith TNF-a a lone (n=5) 
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I have consequentely used the previously described compounds to pharmacologically 
dissect the contribution of the different SMase activities to the initial phase of apoptosis 
triggered by the administration of TNF-a in the presence of the protein synthesis inhibitor 
cycloheximide (CHX, 1 Jlg/ml), a usual paradigm for studying apoptosis by TNF-a 
(DeNadai et ai, 2000). 
Of importance, CHX preincubation did not alter the SM conversion profile (A-SMase: 
20-4 pmol/mg min- I ; N-SMase: 10±3 pmol/mg min- I ) ruling out a possible interference 
effect of CHX on SMase activation. All the subsequent experiments were therefore 
performed in the presence ofCHX. 
2.3b) Caspase-8 activation 
We have analyzed another initial hallmark of apoptotic signalling by TNF-a, that is the 
activation of caspase-8, which was measured by two different techniques. 
Cleavage of a specific fluorescent substrate, N -acetyl-I ETOE-7 -amino-4-
tritluoromethilcoumarin, was measured with the tluorimeter. Basal activity of caspase 8 
was 1O±1 pmol/mg min-1 of converted specific substrate, and rose 75% after 5 minutes of 
treatment with TNF-a/CHX. The pre-treatment of the cells with only the various SMase 
pertinent inhibitors didn t alter the basal level of caspase-8 activity, ruling out any effect of 
the drugs on this feature, at least in the considered time frame. 
The TNF-a stimulated increase of caspase-8 activity was specifically inhibited by pre-
incubation of the cells with imipramine, 0609 and with monensin, while neither 
scyphostatine nor L-carnitine had any relevant and significant effect on this parameter 
(Figure 2.5). 
Consistent with this result, A-SMase inhibitors prevented the reduction in the amount of the 
uncleaved and inactive procaspase-8 by TNF-a with respect to the control, as indicated by 
western blot experiments of Figure 2.58. As an internal control I measured cleavage of 
procaspase-3, which get cleaved later during apoptosis progression. Caspase-3 was not 
affected by the treatments, as shown by relevant band in the western blot of Figure 2.68. 
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Figure 2.5) In vo lvement of A-SMase in caspase-8 acti vation trigge red by TNF-a/CHX. 
U937 ce ll s we re treated with TNF-a (50 ng/ ml ) in the prese nc of the indicated 
compounds (desc ribed in the previous fi gure legend an'd in the text). Caspase 8 activ ity was 
measured a fte r 5 minutes by two independent mean: flu orimetri c measure o f a caspase-8 
spec ific substrate CA) and Weste rn Blot analysis CB, upper panel) of proteolys is of the 
inac ti ve zymogen, procaspase8. no ne o f the treatment results in proteo lysis ofprocaspase-3 
(B, lower panel), a downstrea m e ffector caspase, used in thi s case as an inte rna l control. 
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2.3c) DNA fragmentation 
[then evaluated the effects ofSMases on two more . downstream" steps ofapoptosis: DNA 
fragmentation and phosphatidyl-serine exposure to the outer leaflet of the plasma 
membrane. 
DNA fragmentation was evaluated by the established method of filter binding assay 
(DeNadai et ai, 2000). We checked the amount of fragmented DNA at various time points 
(1, 2 and 3 hours) after TNF-a/CHX treatment in the presence of the various SMase 
inhibitors. As showed in Figure 2.6, the pre-treatment with A-SMase inhibitors resulted in 
a considerable inhibition of DNA fragmentation in the 3 h time window, while N-SMase 
inhibitors didn t alter in any way the profile of fragmentation. 
The pretreatment of the cells with the various compounds, in the absence ofTNF-a stimuli, 
didn t cause any alteration of DNA fragmentation, with the percentage of fragmentated 
DNA that wasn t different from the basal level of5% (see figure 2.6). 
We next investigated whether the early mechanism of drug protection has any role also in 
the progression of the apoptotic process, by measuring the kinetics of DNA fragmentation 
after the 3 hours time window: Table 2.1 shows this parameter after 4.5 and 6 hours after 
administration of the death stimuli. Protection exerted by 8Br-cCMP and by the A-SMase 
activity inhibitors, imipramine and D609, even if reduced compared to that measured at 3 
hours, was still significant after 4.5 hr. At 6 hours instead protection exerted by these 
compounds was not detected anymore. 
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Figure 2.6) Involvement of A-SMase in DNA fragmentation triggered by TNF-a/CHX 
V937 cells were treated with TNF-a/CHX (50 ng/ml) in the presence of the already 
described drugs and DNA fragmentation, evaluated by the filter binding assay, was 
analysed at the indicated times after cytokine stimuli indicated in the X axis. 
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Table 2.1) Inhibition by cGMP and potentiation by A-SMase ofTNF-a-induced apoptosis 
are transient events 
time (h) 3 
TNF-a 65±5 
TNF-a + 8 Br-cGMP 27± 2*** 
TNF-a + imi 33 ± 5*** 
TNF-a +D609 31±2*** 
DNA fragmentation (%) 
4.5 6 
82± 5 94±4. 
59.5 ± 3** 88 ± 5 
62 ± 4** 96 ±6 
64 ± 5* 93 ± 5 
U937 cells were treated with TNF-a (50 ng/ml)/CHX (1 ",g/ml) with or without 8 Br-
cGMP (1 mM), imipramine (imi, 20 ",M) or D609 (25 !!g/ml). DNA fragmentation was 
measured after 3, 4.5 and 6 h of incubation with the cytokine, as detailed in the Materials 
and Methods section. Values are expressed as % ± s.e.m. Statistical values in the various 
samples are measured vs. cells treated with TNF-alCHX (n = 8). 
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2.3d) Phosphatidyl-serine exposure 
Phosphatidyl-serine exposure to the outer leaflet of the plasma membrane occurs early 
during apoptosis, and can be measured by cyto-fluorimetric analysis of fluorescein-Iabelled 
annexin V. The latter protein specifically interacts with phosphatidyl-serine residues. I have 
measured the appearance of annexinV-positive cells after three hours of treatment with 
TNF-a, testing, again, the role of each SMase by the use of the above mentioned A- and N-
SMase inhibitors. 
I found that the preincubation of the cells with A-SMase specific inhibitors caused a minor 
positivity of the cells to annexinV staining, (see Figure 2.7), while pre-treatment with only 
N-SMase inhibitors didn t have any relevant effect on the same parameter. As in the other 
previous experimental settings, pre-treatment of the cells with these compounds alone 
didn t have any consequence in term of apoptotic marker staining. 
Taken together these results indicates that A-SMase contributes to early apoptotic features 
of TNF -Cl signalling, while N-SMase seems not to be involved at least in this stage of the 
apoptotic process. 
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Figure 2.7) Involvement of A-SMase in phosphatidyl-serine exposure triggered by TNF-
a/CHX 
U937 cells were treated with TNF-a/CHX (50 ng/ml) in the presence or absence of 
indicated compounds, and annexin V staining was analysed at the cytofluorimeter after three 
hours of incubation with the cytokine. The annexin V staining profile of untreated cells is 
super-imposable to that of unstained cells. 
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2.4) cGMP dependent inhibition of acidic-sphingomyelinase accounts for apoptosis 
protection 
I then investigated whether the cGMP dependent inhibition of A-SMase activity shown in 
Figure 2.2 could account for the NO/cGMP dependent protection from TNF -a-induced 
early apoptosis that was described by DeNadai et al (2000). To this end I have examined 
directly the effects ofthe cyclic nucleotide. 
As shown in Figure 2.8 administration of 8Br-cGMP inhibited both caspase 8 activation 
(Figure 2.8A) and DNA fragmentation (evaluated at the 3 hours time point; Figure 2.88) 
triggered by TNF-a (5 minutes). When the cyclic nucleotide was administered together 
with imipramine, monensin or D609, neither caspase8 activation nor DNA fragmentation 
were inhibited further. The lack of a synergistic effect on the apoptotic feature indicates that 
the inhibition by the two applied agents occurs at the same signalling event. On the other 
hand, the administration of the long chain natural C 16 ceramide (30 J.lM) reversed the 
effects of 8Br-cGMP and A-SMase inhibitors on both TNF-a/CHX triggered caspase8 
activation and DNA fragmentation. 
When administered alone, and at the concentrations and for the time window employed, 
C 16 had effect neither on caspase8 activation or DNA fragmentation, indicating that 
ceramide action is exerted only when the apoptotic signalling is activated by TNF-a 
treatment, that is upon DISC complex formation. 
Taken together, the data presented in section 2.1-4 strongly indicate that NO is able to 
inhibit both A- and N-SMase through a pathway involving generation of cGMP and 
activation of the protein kinase G, which had not yet been considered. Inhibition of the A-
SMase and of the ensuing generation of ceramide seems to account for the cGMP 
dependent, early inhibitory effect of NO on TNF-a-induced apoptosis. The results obtained 
measuring level of DNA fragmentation after 6 hours 'show that inhibition of A-SMase by 
NO/cGMP delays, rather than totally preventing, the TNF-a/CHX induced apoptosis. Thus, 
modulation of A-SMase by NO/cGMP acts as a regulatory mechanism rather than a switch 
off system. 
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Figure 2.8 ) Inhibition of A-SMase by 8Br-cGM P accounts for its ability to reduce TNF-
a /CHX induced caspase-8 activation and DNA fragme,ntation 
All treatments showed in the fi gure were carried out as described in the previous legend 
and in the text; C 16 ceramide concentration was 30 ~M (cer), Treatments were carried out 
in various combinations as indicated in the y ax is. Caspase 8 activity (A) was measured 
after 5 minutes, while DNA fragmentation (B ) afte r 3 hours of incubation with the 
cytokine. Control in each panel represents caspase ac ti vity (absolute values for caspase-8 
activity : untreated cells I O± 1 pmollmg min-I ; TNF-a treated cells 18± 1 pmollmg min-I ) or 
DNA fragmentation induced by TNF-a/CHX alone (n=5) . In both panels statist ical values 
are measured vs ce lls treated with TNF-a/CHX (control) (n=6) 
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Effect of endogenous NO on TNF-a induced cell death in HeLa/NOS tet 
off cells 
2.5) Construction and characterization of HeLaJeNOS tet-off cells 
2.5a) Transfection and Western blot 
In order to analyse the possible effects of endogenous NO on cell death signalling triggered 
by TNF-a, we decided to build up a system where eNOS expression could be conditionally 
induced. To this end, we used the Tet-off system, which, by allowing comparison between 
the 'switched on" and 'switched off' state of transcription of the transfected cDNA, 
permits direct assessment of the consequences of expression of the considered gene in an 
internally controlled and regulated system. 
Experiments were conducted with HeLa tet off cells commercially available from 
CLONTECH, made stably transfected with a bovine eNOS cDNA (kind gift of William C. 
Sessa), put under the control of a tetracycline repressed promoter. The tet off system 
(Gossen and Bujard, 1992) allows controlled expression of a single gene by the 
presence/absence in the culture medium of tetracycline or of its derivative doxycycline. 
This represents therefore a precious tool to study the direct effect of the expression of 
eNOS in the context of TNF-a signalling, since it permits to compare cells originally not 
endowed with the enzyme with cells where eNOS has been forced to be expressed. 
We proceeded with transfection of HeLa Tet-off cells with eNOS cDNA cloned in the p-
TRE plasmid by CLONTECH, together with a plasmid conferring resistance to 
hygromycin. 30 hygromycin resistant clones were obtained and expanded, of which 6 
expressed eNOS when doxycycline was removed from the culture medium: this was 
established by western blotting and immuno-fluorescence. I carried out a detailed 
characterization on one of the selected clones, which was named clone Ao. 
I analyzed the time course of induction of expression of eNOS by doxycycline removal 
from the culture medium as seen in Figure 2.9A: the gel lanes were loaded with 10 J.1g of 
lysates prepared from cells cultured for the indicated time in absence of doxycycline. 
Removal of doxycycline did cause the rapid induction of eNOS expression, detected as a 
140000 Mr band using a monoclonal anti-eN~S antibody. The relevant band was already 
present 4-6 hours after removal of doxycycline, and continued to increase until 72 hours, 
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when expression reached a steady state. Equal protein loading was internally controlled by 
~-actin staining on the same nitrocellulose filters. 
I also investigated the dependency of eNOS levels on doxycycline concentration as 
reported in Figure 2.98: induction was detectable at doxycycline concentration less than 
0.1 ng/ml. With decreasing doxycycline concentration eNOS expression was progressively 
increased, reaching its maximum in the absence of the antibiotic. In all the cases we 
checked eNOS expression after 72 hours of doxycycline removal from the medium. The 
level of eNDS in HeLa Ao after 72 hours of induction was comparable to the endogenous 
eNOS present in an endothelial cell line (E2 cells, a kind gift of Elisabetta Dejana). 
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Figure 2.9) rmmunoblots of proteins from HeLa tet-off ce lls. 
A) Cell s were grow n to confluence in the pre ence of doxicyc lin e, then split and 
incubated in smaller di shes in the ab ence of doxicyc line for the indicated time 
points. 
8 ) Cell s were cultured as above, but, afte r b ing split , they were cultured in the 
presence of 1, 0.5, 0.1, 0.05, 0.01, 0.00 I and 0 ng/ml doxicyc line for 72 hour 
(lanes 1-7) 
Cell Iy ates were subjected to SOS-PAGE and the re ulting nitrocelllllo e filter were 
probed with an either an anti-eN OS (arrowhead, upper panels of A and 8) or with an 
anti-~-actin antibody (as terisks, lower panel of A and 8 ) 
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2.5b) Sub-cellular localisation of eNOS 
By means of immunocitochemistry analysis we then investigated whether the enzyme, 
expressed after doxycycline removal from the culture medium, has a localisation similar to 
that described in the literature. As showed in Figure 2.10 eNDS immunoreactivity was 
found to be most concentrated in a perinuclear zone and at the cell surface. 
The perinuclear staining represent a Golgi region staining, as it is showed in Fig 2.10A-G 
by colocalisation of eNDS with the Golgi marker giantin in the same fields of cells in 
double immunostaining experiments and con focal analysis of the specimen. This is 
consistent with reports in the literature about localisation of the native enzyme in 
endothelial cells (Sessa et aI, 1995). 
We have also performed a close examination of eNDS surface distribution by double 
immunostaining experiments of eNDS with green fluorescent phalloidotoxin, a specific 
label for cytoskeletal actin as it is showed in Figure 2.10 G-1. In these series of confocal 
images it is well recognisable that the enzyme is concentrated in areas of the plasma 
membrane enriched in cortical actin, an interesting and novel finding which could have a 
functional meaning, whose exploitation is the aim of a side project. I won t describe in this 
thesis the results obtained with this project. 
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Figure 2.10) Double-staining immunofluorescence of HeLa tet-off cell 
A-F) Cells expressing eNOS were doubly stained with monoclonal anti-eNO and 
polyc1onal anti-giantin antibodies, followed by fluore cein-labeled anti-mou e IgG CA and 
D) and rhodamine-conjugated anti-rabbit IgG (B and E) . Panel A-C show the ame field of 
cells viewed at the fluorescent microscope under the fluore cein filter for eNO CA), the 
rhodamine filter for giantin (B) and in phase contra t (C): eNOS appear concentrated on 
the surface and in perinuclear structure corresponding to the Golgi region, a hown by the 
giantin staining CB). Panel D-F shows a confocal micro copy analysi of a single cell: 
eNOS CD) and giantin CE) images are superimposed to the tran mitted light image, and co-
localization of the two is showed by the yellow color in' the merged imag (F) 
G-L) Cells expressing eNOS were stained with monoclonal anti-eNO antibody followed 
by rhodamine-conjugated anti-mouse TgG (G) and with fluore cein-Iabelled phalloidotoxin 
CH). the merged images (I) show co-localization of eNOS with cortical actin, as 
demonstrated by the appearance of yellow colour, 
Bar in panels A-C: 15 /lm; panels D-F: 10 /lm; panel G-I: 20 /lm 
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2.Sc) Transfected eNOS activity and cGMP assays. 
To functionally characterize the transfected HeLa cell line in terms of eNOS activity and 
NO generation, I measured the Ca2+ dependent eNOS activity by assaying the conversion of 
the radiolabelled, L-[3 H]-arginine into the reaction product, L-citrulline, produced in a 
stoichiometrical quantity to NO. 
These assays were carried out on cell lysates of cells cultured in presence (NOS negative) 
and absence (NOS positive) of doxycycline. Various conditions were employed to evaluate 
the Ca2+ dependency of the enzyme: in the presence ofCa2+ (0.45 mM), in the presence of 
Ca2+ (0.45 mM) and the calcium chelator EGTA, and in the presence of Ca2+ (0.45 mM) 
plus the NOS inhibitor L-nitro mono-methyl arginine (NMMA, 0.5mM). Radioactive 
labelled substrate and product of the reaction were then separated by mean of ionic 
exchange cromatography as first showed by Bredt and Snyder (1989), using the strong 
cationic exchange resin Dowex 50X8-400. 
Results are shown in Figure 2.l1A. Citrulline formation in eNOS expressing (dox-) cells 
was stimulated by the presence of Ca2+ to a level, 2.5 pmol/mg min- 1, comparable with 
those reported in the literature for endothelial cells (see e.g. Shaul et ai, 1996), and 
corresponding to a value 360% over the activity observed in the presence of the 
Ca2+ chelator EGT A. The Ca2+ dependent activity was almost completely abolished by the 
presence in the reaction buffer of the NOS inhibitor L-NMMA. In cells not endowed with 
the presence of the enzyme (dox+), instead, neither L-NMMA nor EGT A caused 
significant changes in citrulline accumulation, and the absolute values of citrulline formed 
in the presence of only Ca2+ were significantly lower with respect to those obtained in do x-
cells. 
We repeated the same kind of experiment, but instead oflysates using HeLa intact cells that 
were exposed to ATP, an agonist of (P2Y) receptors known to increase [Ca2+]j. ATP 
increased the accumulation of L-citrulline with resp~ct to untreated controls only in eNOS 
expressing cells (dox-); this effect was inhibited by the cell permeant NOS inhibitor L-
NAME (see Figure 2.11B). We measured [Ca2+]j by means of fura-2 fluorimetric analysis 
in both dox + and dox- cells after A TP treatment and the results were superimposable, 
showing a rapid peak increase followed by a return to the baseline (see Figure 2.17 A) 
To investigate whether eNOS expressing cells are able to generate bioavailable NO, we 
measured formation of cGMP, a good proxy for NO since GC is activated by nanomolar 
concentration of the gas (Denninger and Marletta, 1999). In cells grown in the presence 
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of dox exposure to A TP for 15 minutes did not result in any increase in cGMP over non 
stimulated control cells (0.38-0.1 and 0.35-0.1 pmol/mg min- I respectively, n=4). In 
eNOS-expressing cells, administration of ATP resulted in a modest increase in cGMP 
formation over controls (0.44-0.1 and 0.33-0.1 pmol/mg min -I, respectively with n=3) 
suggesting that the cells are expressing very low levels of sGC. 
Taken together the results summarized up to now have revealed limitations of the He La cell 
system to investigate NO generation. Therefore, to assess the formation of bioavailable 
nitric oxide upon cell treatment, we chose to integrate HeLa with another cell type, the rat 
pheochromocytoma PC 12, as a reporter system: these cells were chosen because they 
respond to NO with a dramatic increases in cGMP (0.33-0.1 and 9,4-1 pmol/mg min- I 
before and after exposure to 100 JlM of the NO donor SNAP, respectively, n=3), whereas 
they do not generate NO when treated with ATP (untreated cells 0.33-0.1 pmol/mg min- I ; 
ATP treated cells 0.35-0.1 pmol/mg min- I ). 
As shown in Figure 2.12, co-incubation of HeLa with PC12 cells caused a rise of cGMP 
after administration of ATP, which was inhibitable by the preincubation ofL-NAME in the 
cell mixture. As expected, no changes in cGMP content were observed with cells grown in 
the presence of doxycycline. 
The results reported so far indicate that in our eNOS Tet-off system is endowed with a 
functional eNOS that can be controlled in term of expression. This property offered us a 
flexible and informative cellular tool to directly challenge the question of whether eNOS 
expression has consequences in term ofreguiation ofTNF-a. triggered apoptosis. 
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Figure 2.11) Characterization of eNOS activity in HeLa tet-off ce lls 
A) Ca2+ dependence of eNOS activity in ce ll Iysates prepared from ce lls grown in the 
presence (dox +) or in the absence (dox-) of doxycicline for 72 hours . Lysates had 
been resuspended in a L-CH]-Arginine containing reaction buffer containing 0.45 
mM CaCh (Ca2+), 0.45 mM CaCh and 1 mM EGTA (E GTA ) or 0.45 mM CaCh 
and 500 !lM L-NMMA (L-NMMA), and incubated for 10 minutes at 37j . 
B) Ca2+ dependence of eNOS activity in intact cells. Ce ll s monolayers, grown in the 
presence or absence of doxycycline (indicated as above) were incubated for 15 
minutes at 37j in a L-eH]-Argin ine medium, alone (Colltrof) , in the pre ence of 
100 IlM ATP (A TP) or with 100 mM ATP and 500 IlM L-NAME (ATP +L-
NAME) . 
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Figure 2.12) cGMP generation by the HeLalPC 12 reporter system 
cGM P generation induced in PC 12 ce ll s induced by acti vati on of eNOS in HeLa ce ll s. 
2x l06 HeLa tet-off ce ll s, grow n in the presence or absence of doxycycline, were 
resuspended together with 0.5x 106 PC 12 ce ll s and incubated for 15 minutes at 37 i in the 
same conditions described in the legend of Figure 11 B. cGMP accumulation was estimated 
by a radioimmunoasssay and normali zed to protein co ntent. 
Stati sti ca l signifi cance indicated by asteri sk is calculated ve rsus untreated control ce ll s; 
when indicated by the crosses it is instead calculated versus the absence of L-NAM E. 
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2.6) eNOS expression modulates TNF -a induced cell death 
To investigate the effect of eNOS expression on TNF-a induced cell death, cells grown in 
presence or absence of doxycycline were treated overnight with TNF-a together with the 
protein synthesis inhibitor CHX. To characterize the system I have measured by flow 
cytometry two different and independent aspects of cell death: the appearance of 
phosphatidylserine to the outer leaflet of the plasma membrane (as measured by fluorescent 
Annexin-V staining) as well as the formation of small size hypodiploid DNA fragments. 
Results are shown in Figures 2.13 and 2.14. Annexin V stained cells were 
indistinguishable from unstained cells (not shown), and basal levels of Annexin V staining 
were the same in cell cultured in the presence (Figure 2.13a) and in the absence (Figure 
2.13c) of doxycycline. Therefore expression of eNOS has no effect on basal levels of cell 
death. 
Incubation with TNFa-CHX resulted in both cases in the appearance of annexin V -positive 
cells, reflecting the increased exposure of phosphatidylserine to the plasma membrane 
(Figures 2.13b and d), albeit at a significantly lower extent in eNOS expressing cells with 
respect to cells not expressing the enzyme (see also table 2.2 for the quantification). 
Similar results were obtained with the analysis of the hypodiploid DNA content. After 
treatment with TNF-a/CHX levels were significantly higher in eNOS-negative (Figure 
2.14b) than in eNOS-positive cells (Figure 2.14d, see also Table 2.2 for quantification). 
These results show that expression of eNOS is sufficient to exert an inhibitory modulation 
of the TNF-a apoptogenic signalling. 
Next question was whether the activity of the enzyme, and hence the production of NO, is 
necessary to exert this modulatory action. In order to investigate the problem I have 
repeated the above described experiments in presence of the NOS inhibitor, L-NAME. In 
untreated cells treatment of dox- cells (bottom row ill: Figure 2.13) cells with this inhibitor 
did alter neither Annexin V (Figure 2.13e) staining nor the levels of hypodiploid DNA 
content (Figure 2.14e): by contrast when TNF-a/CHX was administered to NOS-positive 
cells, both parameters were significantly increased to levels that were not significantly 
different to those observed in the non induced cells. 
This effect was specific since in dox+ cells L-NAME preincubation did not have any effect 
(see Table 2.2 for quantification). These results confirm that the expression of functional 
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eNOS is able to exert an inhibitory effect on TNF-a induced apoptosis via the generation of 
NO. 
phosphatidyl serine 
Control TNF-u/CHX 
H h 
Ml Ml 
dox+ 
d 
.. Ml Ml 
• 
dox- 1 ~ 50 
= 
• u 
r 
Ml Ml 
dox-
L-NAME 50 
o 
1 3 1 . 3. 
log fluorescence Intensity (arbitrary units) 
Figure 2.13) Effect of eNOS expression on TNF-a-in~uced phosphatidyl serine exposure 
Cell monolayers, grown in the presence (dox+) or in the absence (dox-) of doxycycline 
were incubated for an additional 12 hours without (Control) or with (TNF-a/CHX) TNF-a 
(100 ng/ml) plus CHX (l~g/ml). L-NAME(500 ~M) was added to the incubation where 
indicated. Annexin V staining was measured with the cytofluorimeter. No significant AxV 
staining was seen in control cells exposed only to the protein synthesis inhibitor (for dox+ 
percentage of cells present in the data region considered for statistical analysis in the 
presence of only CHX was 5-1 %, for dox- cells it was 6-2) 
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Figure 2.14) Effect of eNOS expression on TNF-a induced hypodiploid DNA increase 
Cells grown and incubated as in the Figure 2.13 legend, were fixed. Propidium iodide 
staining of the fixed cells was assayed to measure DNA content. In these experiments HeLa 
cells were not synchronized. Accordingly GO/G 1, Sand G2/M phases were present as 
already described for He La cells (see Rodriguez and Flemington, 1999). The sub-Gl, 
hypodiploid peak, characteristic of apoptosis is clearly detectable in b, d and/with respect 
to the control cells Ca, c and e). Ml indicates the region considered for statistical analysis. 
The pre-treatment of cells with CHX only did not alter the number of cells with an 
hipodiploid DNA content in the region considered for statistical analysis: dox+ cells 
17-4%, dox- cells 15-5%. 
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Table 2.2: effects of eNOS expression on the TNF -a.-induced exposure of phosphatidyl serine and 
formation of hypodiploid DNA 
annexin V staining propidium iodide staining 
control TNF-alCHX control TNF-a/CHX 
*** *** 
+++ ++ 
dox+ 5-1 41-2 17-1 66-3 
*** ** 
dox+ / L-NAME 5-1 45-2 18-1 65 - 5 
*** *** 
dox - 5 - 1 21-1 16-1 46-2 
*** *** 
+++ ++ 
dox- / L-NAME 7-1 43-2 17-1 60-3 
HeLa Ao cells, cultured in the presence (dox+) or absence (dox-) of doxycycline, were either 
treated with TNF-a. (100 ng/ml) and CHX (l M) for 12 h, or left untreated (control), before flow 
cytometry analysis of annexin V and propidium iodide staining, as described under Materials and 
Methods chapter. Values represent the percentage of cells measured in the Ml regions, defined as 
shown in Fig. 2.13 and 2.14. Statistical probability vs controls is indicated by the asterisks, that of 
dox+ vs. dox- and dOX-/L-NAME vs. dox- cells after TNF-a./CHX treatment by the crosses, both 
calculated as described under Materials and Methods (n = 4). 
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2.7) TNF-a stimulation increases eNOS activity and NO generation 
To investigate whether the effect of NO modulation was exerted by a tonic activation of 
eNOS or by an acute stimulation of the enzyme following apoptotic stimuli, we 
investigated the effect of a 15 minute stimulation with the cytokine on the 
arginine/citrulline assay in intact cells, as well as the production of cGMP in the 
HeLalPC 12 reporter system. 
As shown in Figure 2.15A, citrulline accumulation was stimulated by TNF-a in eNOS 
expressing HeLa cells (dox-). Consistently, co-incubation of HeLa cells stimulated with 
TNF-a with PC-12 induced an increased cGMP generation in the latter (Figure 2.158). 
Both of these effects were prevented by the preincubation of HeLa cells with the NOS 
inhibitor, L-NAME. Of importance, neither of these effects was observed in cells not 
expressing eNOS (dox+). I next investigated the pathway through which TNF-a induces 
eNDS activation. The cytokine did not induce any increases in [Ca2+]i' ruling out a major 
role of the cation in eNOS activation (Figure 2.15C). I then studied whether TNF-a 
induced eNOS activation is due to stimulation of the Pi3K1 Akt pathway, with ensuing 
activation of eNOS phosphorylation in the Serll79 residue. To this end, I carried out 
Western blot experiments with an antibody recognizing eNOS specifically phosphorylated 
in Serl179, standardized by using a monoclonal antibody recognizing both the 
phosphorylated and the unphosphorylated form of the enzyme. These blots revealed the 
appearance of a phospho-specific band in the cells stimulated with 10 minutes TNF-a 
(Figure 2.15D). 
As shown in Fig 2.16A, TNF-a treatment of HeLa cells resulted also in the 
phosphorylation of Akt on its Ser 473 residue (associated with activation, see Alessi et ai, 
1996), which was specifically inhibited by preincubation of the cells with the Pi3K 
inhibitor, wortmannin. Remarkably the wortmanniri preincubation also inhibited eNOS 
activation, as showed by western blot (see Figure 2.168) as well as by arginine/citrulline 
assay (see Figure 2.16C). 
These results indicate that eNOS activation by TNF-a occurs through activation of the 
Pi3K1Akt pathway and phosphorylation of eN OS on its Ser 1179 residue. 
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Figure 2.15) Effect ofTNF-a treatment on NO generation in HeLaltet-off ce lls 
A) eNOS activity induced by TNF-a assayed in intact cells. Ce ll monolayers grown 
with (dox+) or without (dox-) doxycyc line, were incubated for] 5 minutes at 37 i in 
a medium containing L-eH]-arginine with or without TNF-a (100 ng/ml) and/or L-
NAME (0.5 mM) 
8) effects of TNF-a treatment on cG MP generation by the PC I2 reporter system. 
2x 106 HeLa ce lls were resuspended with 0.5x 1 06 P 12 cells, and were treated for 
15 minutes without (control) or with (TNF-a) TNF-a (100 ng/ml ) and without or 
with L-NAME (0.5 mM ; TNF-{l + L-NAME) 
C) Western Blot analysis of HeLa dox- cells treated for 10 minute with TNF-a (100 
ng/ml) . The upper panel: antibody aga inst phosphorylated eNOS. Lower panel: 
same membrane immunoblotted with an antibody against total form of eNOS . 
D) [Ca2+]i levels induced by TNF-a in eNOS tet-off ce ll s loaded with the a2+ sensitive 
fluorescent dye fura-2A M. The st imulus was added when indicated by the arrow , 
and the [Ca2+]1 sca le is reported on the left hand side. 
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Figure 2.16) eNOS ac ti vation by TNF-a involves Pi 3K activation. 
P-eNOS 
eNOS 
eNOS expressing HeLa ce ll s were treated for 10 minutes with TNF-a (100 ng/ml), with 
or without wO l1mann in (Wort. 100 nM). Ce ll s were Iy ed and sa mpl es ana lysed by 
wes tern blot with ant ibodies recognizing (A) either the phosphorylated Ser473 form 
(upper panel; P-Akt) or the whole Akt (lower panel: Akt) . Western blot analys is was 
also performed with antibodies recogni sing eNOS (B),either in it phosphorylated Ser 
11 79 form (upper panel; P-eNDS) or a a whole (lower panel; eNDS) . 
C) I have also measured eNOS activity in the ame condit ions as above, measuring the 
argi nine/citrulline conversion by whole ce ll s. Stati st ica l probability i indicated by 
the asterisks and calculated vs ce ll s treated with only TNF-a. (n=5) 
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TNF-a induced activation of eNOS had not been described previously, so I decided to 
characterize further this pathway by comparing the time course of activation of the enzyme 
by the cytokine with that induced by other two stimuli: EGF, a growth factor known to 
directly activate the Pi3K1AKT signalling (Wang et ai, 1998), which does not increase 
[Ca2+]i in our cells (Fig 2.17A), and ATP, an agonist which raises [Ca2+]i (Fig 2.17A) 
without concomitant Akt activation. TNF-a did not induce changes in [Ca2+]i. ruling out a 
possible involvement of the cation in the pathway. 
In order to carry out these experiments, I adopted a slightly modified arginine/citrulline 
assay on whole cells, where the radioactive substrate was administered at different time-
points after the challenge with the stimuli. This experimental protocol gave us the 
opportunity to measure the time-course of L-arginine conversion to L-citrulline rather than 
the accumulation of the latter as evaluated in the previous experiments. 
Results of this approach are shown in Figure 2.17B. The percentage value reported for 
each time point represents the value of citrulline accumulation obtained with the indicated 
stimuli versus the citrulline accumulated in untreated cells, run in parallel as internal 
controls. 
A TP caused a transient citrulline accumulation which peaked at 2 minutes and rapidly 
faded out, returning to the basal levels after 6 minutes: this profile of activation is 
consistent with the rapid and transient peak of [Ca2+]i caused by the compound and showed 
by fluorimetric fura-2 analysis in Figure 2.17 A. 
In contrast to ATP, TNF-a gave rise to a slower activation of the enzyme (see Figure 
2.17B). Citrulline levels began to rise with an appreciable delay from cytokine 
administration, being visible after 6 minutes, with a peak after 10 minutes and return to the 
baseline after 15 minutes. In contrast, EGF treatment resulted in a rapid onset of citrulline 
accumulation, with levels remaining above controls until 20 minutes and then declining to 
resting levels within half an hour from the start of the treatment. None of these effects were 
present in cells not endowed with eNOS expression (data not shown). 
I then compared the time course of activation of eNDS, measured by citrulline 
accumulation, with the activation of Pi3K1AKT pathway and eNOS phosphorylation. The 
patterns induced by TNF-a and EGF were quite different. EGF stimuli did cause a rapid 
activation of AKT, already visible after two minutes of treatment with the growth factor, 
while treatment with TNF-a followed the same delay as observed by measuring eNOS 
activity, with a strong signal visible after 5 minutes from the treatment with the cytokine. 
Results 89 
EGF induced phosphorylation of eNOS with a time course matching closely that of eNOS 
activity, with a rapid increase followed by a decrease after 20 minutes, and by a complete 
switch off after 30 minutes. 
Similarly, the pattern of TNF-a-induced eNOS phosphorylation matched that observed by 
measuring eN OS activation. TNF-a phosphorylated eNOS with a delay comparable to that 
induced by EGF, reaching a peak after 10 minutes, decreasing at 15 minutes and reaching 
basal levels after 20-30 minutes from initial stimulation. Of importance, Akt 
phosphorylation induced by TNF-a persisted longer (half an hour, with complete switch-off 
after 1 hour: data not shown) compared to eNOS phosphorylation and activity, whereas a 
dissociation between Akt and eNOS was not observed with EGF. A TP caused neither Akt 
nor eNOS phosphorylation. 
Taken together these results show that the Pi3 KI Akt module signalling pathway, although 
able to able to sustain and regulate the activation of eNOS by TNF-a and EGF, is 
di fferentially regulated. 
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Figure 2.17) Different pathways of eNOS activation. 
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A) [Ca2+]i increases induced by ATP and EGF in eNOS tet-offcells loaded with the Ca2+ 
sensitive fluorescent dye fura-2AM, estimated at the cytofluorimeter. The different 
stimuli were added when indicated by the arrows, and the [Ca2+), scale are reported on 
the left hand side. Traces are representative of 5 experiments 
8) eNOS-expressing HeLa tet-off cells were treated with ATP (100 JlM), EGF (100 ng/ml) 
or TNF-a (100 ng/ml) at time O. L-eH]-arginine was added at the time points indicated 
in the X axis; the reactions were stopped every 2 minutes. eNOS activity was estimated 
as pmollmin ofL-eH]-citrulline formed in the 2 minutes time window, and normalised 
to the protein content. Results are here expressed as mean % of the increased L-
eH]citrulline formation over basal, i.e. the untreated cells. 
Resulls 9 1 
A 
time (min) 0 2 5 10 15 20 30 
P_Aktl 
Akt 
ATP 
P-Akt I EGF 
Akt 
P-Akt I TNF-a 
--
Akt ...... 
B 0 2 5 10 15 20 30 
p-eNosl 
eN OS ~ ATP 
P-eNOS 
EGF 
eNOS 
p-eNosl - I TNF-a 
eNOS ' 
Figure 2.18) Patterns o f Akt (A) and eNOS (B) phos~hory l atio n by different stimuli 
eNOS express ing HeLa tet-off cell s were treated with ATP ( lOO J..lM) , EGF (lOO ng/ml) and 
TNF-a (100 ng/ml ) and the reactions stopped at the indica ted time points, by quick transfer 
of the di shes to ice and lysing o f the ce ll s. Western blot of active, phosphory lated Akt (A: 
P-Akl) and eNOS (B; P-eN DS) vs total (Akt and eN DS) , non-phosphorylated enzymes was 
estimated out as indicated in Figure 2.16 legend. 
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2.9) Role of sphingomyelinases in TNF -a-induced activation of eNOS 
eNOS had been previously reported to be activated by exogenous ceramide (Igarashi et ai, 
1999): I thus decided to investigate the role of SMase activities in the context of TNF-(l 
triggered eNOS activation. eNOS-Tet off cells were treated with TNF -<X for 5 minutes and 
SMase activity was measured in celllysates at the optimum pH for either enzyme (pH 5.5 
and 7.4 for A-SMase and N-SMase, respectively), using the same protocol already 
described for U937 cell line. Briefly, SMase activity was evaluated as the increase of 
radioactive phosphorylcholine produced after the stimulation of cell aliquots with TNF-(l. 
As shown in Figure 2.19A and B, both SMase are activated upon the cytokine stimulation, 
with phosphorylcholine accumulation that was incremented by 105% over the basal in the 
case of N-SMase while it was of around 60% in the case of A-Smase (see figure2.19 
legend for the absolute values). 
I have then employed a panel of inhibitors, namely imipramine and 0609 for A-SMase and 
scyphostatin and manumycin A for N-SMase, as suggested by previous reports in the 
literature (Jensen et ai, 1999; Cifone et ai, 1995; Tanaka et ai, 1997, Arenz et ai, 2001 
respectively) and by our results U937 cells (Fig 2.19 A and B). At the concentration used 
0609 (25 Jlg/ml) and imipramine (20 JlM) were found to inhibit selectively TNF-(l induced 
A-SMase activation, while scyphostatin (1 JlM) and manumycin A (5 JlM) appeared 
specific for the N-SMase activity. When administered alone none of the drugs had any 
effect on the basal level of sphingomyelin hydrolysis (for A-SMase: 0609 31-5 pmol/mg 
min- I; imipramine 29-6 pmol/mg min -I; scyphostatin 32-5 pmol/mg min-I; manumycin 
33-5 pmol/mg min- I. Regarding N-SMase values were: D609 10-4 pmol/mg min- I ; 
imipramine 11-5 pmol/mg min- i ; scyphostatin 9-4 pmol/mg min- I ; manumycin 10-5 
pmol/mg min-I). 
The same panel of inhibitors was also tested by western blot analysis (Figure 2.20) and by 
whole cell eNOS assay (Figure 2.21) to try to pharmacologically dissect the contribution of 
the various SMase activities to AKT and eNDS activation. As shown in Figure 2.20 
treatment for 5 minutes with TNF-(l resulted in the activation of both Akt (upper panels) 
and eNOS (lower panels). The use of N-SMase inhibitors did completely abolished the 
TNF-a triggered phosphorylation of both enzymes, while the A-SMase inhibitors did not 
have any effect. 
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Consistent with these results, I found that, similar to the results obtained above, L-citrulline 
induced by TNF-a, was prevented by co-incubation with scyphostatin or manumycin while 
0609 and imipramine had no effect. These results strongly suggest that in this system N-
SMase mediates eNOS activation while A-SMase seems not involved in the process (Fig 
2.21). 
Wortmannin preincubation did change neither the basal rate of sphyngomyelin conversion 
to phosphory1coline nor the increase in phosphorylcoline accumulation induced by TNF-a, 
indicating a site of action downstream of N-SMase activation (Fig 2.22). 
Taken as a whole, these results indicate that TNF-a activates eNOS through a novel 
signaling pathway involving the sequential activation of N-SMase and Pi3K1 Akt. This 
pathway is different from that activated by EGF, whose kinetic has been shown in 
figure 19B, which occurs through activation of Akt without involvement of SMases. 
Results 94 
A ISO 
N-SMase activity 
l OO 
*** 
TNF-a 0609 Imi Scypho Man 
+ TNF-a+ TNF-a + T NF-a+ TNF-a 
B l OO A-SMase activity 
75 
25 
*** 
TNF-a 0609 Imi Scypho Man 
+ TNF-a + TNF-a + T NF-a + T NF-a 
Figure 2.19) TNF-a. activation ofSMases in HeLa tet-offcells: specificity ofSMase 
inhibitors. 
eNOS expressi ng tet-off ce ll s were treated for 5 minutes with TNF-a. (TNF-a; 100 ng/ml), 
with or without either D609 (D609: 25 Jlg/ml), imipramine (Imi: 20 JlM), scyphostatin 
(Scypho: 1 JlM) or manumycin A (Man: 5 JlM) as indicated. The two histogram graphs 
shows the specificity of the act ion of the various SMase inhibitors on the TNF-a. triggered 
N-SMase CA) or A-SMase (8 ) act iviti es, determined in ce ll lysates by measuring [N-
methyl-14C]-sphingomyelin hydro lysis to phosphorylcholine at either pH 7.4 (A: N-SMase 
activity) or 5.5 (8 : for A-SMase activity). Values were expressed as % - s.e.m. over the 
SMase activity measured in untreated ce lls ( 10-4 pmollmg min-I and 33- 6 pmollmg min-I 
for N-SMase and A-SMase respectively) (n=5) 
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Figurc 2.20) TNF-a induced phosphorylation of Akt and eNOS takes place downstream to 
N-SMase: Western Blot analysis. 
eNOS expressing HeLa tet-off ce lls were treated for 10 minutes with TNF-a (100 ng/ml) 
with or without scyphostatin (Scypho: I ~M), manumycin A (Man A: 5 ~M), 0609 (D609: 
25 ~g/ml) or imipramine (/mi: 20 ~M), as indicated. Analysis of phosphorylated, act ive Akt 
(P-Akt) and eNOS (P-eNOS) was performed by western blots, carried out as described in 
the legend of Figurc 2. t 6 (n=4) 
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Figure 2.21) TNF-a induced activation of eNOS takes place downstream to N-SMase: 
arginine/citrulline assay 
eNOS expressing HeLa tet-off cells were left untreated (UT) of treated for 10 min with 
TNF-a (100 ng/ml), with or without L-NAME (0_5 mM)_ Incubations with SMase 
inhibitors were carried on as indicated in Figure 2.19_ eNOS assay was carried out in whole 
cell preparations, as already described, and activity of Arginine/Citrulline conversion was 
estimated as pmol/min of L-[3H]citrulline formed in the reaction_ Results are expressed as 
means - s_e.m. (n=5); statistical significance is indicated by the asterisks and calculated 
versus cells treated only with TNF-a. 
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Figure 2.22) TNF-a induced SMase activation is Pi3K independent 
eNOS-expressing tet-off cells were treated for 5 minutes with TNF-a (100 ng/ml), with or 
without wortmannin (Wart, 100 nM) as indicated. Analyses of (A) N-SMase (absolute 
value in untreated cells: 10-4 pmol/mg min-I ) and (B) A-SMase (absolute value in 
untreated cells: 33- 6 pmol/mg min-I ) activation (n=3) were carried out and reported as 
described in the legend of Figure 2.19.Statistical significance is indicated by the asterisks 
and calculated vs cells treated with only TNF-a. 
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Chapter 3 
DISCUSSION 
The present thesis includes two distinct, yet coordinate, set of studies. The first set was 
aimed at analyzing the role of NO released from an exogenous chemical source on 
proximal events of TNF -a apoptotic signal transduction, investigated in the well 
characterized monocytic cell line U937. In previous studies the U937 line had been widely 
used to investigate TNF-a signalling. The second set concerned the role of endogenously 
generated NO on the same TNF-a apoptotic signalling. For these studies I used a different 
cellular model, generated for this specific purpose: a HeLa tet-off cell line conditionally 
expressing eNDS. The utilization of the latter system has allowed the identification of a 
novel signalling pathway involving the sequential activation of SMase. Pi3K and eNDS. 
From here on, I will therefore discuss the two sets of data separately, while in the last and 
conclusive section I will present a hypothetical model that could help illustrating and 
rationalizing the complicated signalling network activated by TNF-a. Such model 
constitutes a working hypothesis to further understand the complex regulation of the cell 
death process triggered by the cytokine. 
3.1) Exogenous NO and TNF-a Signalling 
Ceramide has been recently recognised as an important intracellular second messenger, 
contributing to a wide series of biological processes such as inflammation, cell growth and 
differentiation. So far, its role has been mainly linked to the induction of apoptotic 
responses (H uwiler et aI, 2000). However the direct target of ceramide in induction of 
apoptosis, as well as its possible role in the regulatio~ of other death inducing stimuli, was 
not yet established. 
Previous results obtained in our lab showed that treatment of U937 cells with ceramide 
potentiates early TNF-a apoptotic signalling as detected by increases in TRADD 
recruitment and caspase-8 activation (see Figures 1.15 and DeNadai et aI, 2000). 
Moreover inhibition of endogenous ceramide generation by NO/cGMP was able to exert 
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inhibitory effects on TNF-a triggered apoptosis. However the targets of the NO/cGMP 
action on ceramide generation remained undefined .. 
I thereby decided to focus on SMases as the possible target. This decision was made for two 
different reasons: the first is that, despite the existence of a de novo ceramide bio-synthetic 
pathway (described in the Introduction), sphingomyelin appears to be the primary source of 
ceramide in the cells, emphasizing the role of SMase for its production. The second reason 
is that, among the various enzyme regulating ceramide concentration in the cell, SMase are 
activated by TNF-a early enough (Wiegmann et ai, 1994; Schutze et ai, 2000) to account 
for the initial wave of ceramide generation, potentially responsible for the effects that we 
had previously shown (DeNadai et ai, 2000). 
I have focused on A-SMase and N-SMase because these were the activities already 
indicated to contribute substantially to death signalling (Higuchi et ai, 1996; Bezombes et 
ai, 1998; Lozano et ai, 2001, Segui et al; 2001 ;Lin et ai, 2000). Death receptor-triggered 
mechanism of SMase activation had been studied: both enzymes, A- and N-SMase, are 
activated early after death receptor stimulation, downstream to recruitment to the 
cytoplasmic site of receptor for proteins such as FAN for N-SMase (Adam-Klages et ai, 
1996; Segui et ai, 2001) and FADD for A-SMase (Chinnayan et ai, 1996; Schwander et 
ai, 1998). Of importance expression of dominant negative of both of these adaptor protein 
bring to long lasting inhibition of apoptosis, which was re leaved only by administration of 
exogenous ceramide (Lozano et ai, 2001; Segui et ai, 2001). 
To investigate the physiological relevance of SMases in early phases of apoptosis induced 
by TNF-a I have investigated in our cell model the role of each enzyme in the regulation of 
caspase 8 activation and in DNA fragmentation. These studies were carried out using a 
panel of structurally unrelated inhibitors of SMase activities, characterized for their 
specificity of action on either enzyme. I have found that A-SMase is involved in the 
regulation of early phases of apoptosis, a result in agreement with a previous report in these 
cells (Schutze et ai, 1999). In contrast N-SMase ~as not involved. The latter enzyme, 
however, is activated not only at early time points. Infact it undergoes also a second wave 
of activation, initiated around 90 minutes after treatment with TNF-a. Therefore a late role 
of N-SMase in the apoptotic process cannot, therefore, be excluded (Segui et ai, 2001; 
Luberto et aI, 2002). 
Current knowledge regarding possible modulation of SMases once they have been activated 
is very limited. A priori, however, such a regulation might be an important keypoint to the 
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modulation of the entire pathway. With the present work I have produced evidence that NO 
might be one of these regulators. In fact NO was able to inhibit in a concentration 
dependent manner, the TNF-a triggered activation of SMase, beginning in the first minutes 
after cytokine administration to the cells. This effect was shown to be cGMP dependent as 
it was mimicked by 8Br-cGMP and inhibited by OOQ. In addition it was found to depend 
upon activation of PK G, a known cellular target for cGMP. It remains to be established 
whether this kinase phosphorylates directly SMases or acts through other intermediate 
protein, as proposed for protein kinase C regulation ofN-SMase (Mansat et ai, 1997). 
Of importance in terms of apoptosis is that prevention, observed after inhibition of the A-
SMase with the three different blockers, was mimicked by SBr-cGMP and not increased 
further by the co-incubation of each of the three inhibitors. This indicates that inhibition of 
A-SMase by NO/cGMP account for its initial protective effect. This is further confirmed by 
the observation that both A-SMase- and cGMP-dependent protections operate only during 
the initial phases of apoptosis, since S-BrcGMP and A-SMase inhibitors lost their 
protective effect as apoptosis proceeded, becoming completely ineffective at later stages (6 
hours). An important implication of these experiments is that NO/cGMP seems to delay 
rather than completely inhibit apoptosis, at least in the particular cellular system 
investigated. 
In our cells NO was found to modulate apoptosis through both cGMP-dependent and -
independent events. The late stage protection was found to be cGMP-independent and to 
depend on the oxidative state of the cells, as suggested by its inhibition by the reducing 
agent OTT (DeNadai et ai, 2000). Late S-nitrosylation might be indeed facilitated by the 
fall in cell reducing potential that occurs in the course of TNF-a induced apoptosis 
(Higuchi et ai, 1998). GSH is an important inhibitor of N-SMase. Decrease of GSH 
concentrations during TNF -a triggered apoptosis might provide an explanation for the 
delayed and persistent activation of N-SMase observed after 60-90 minutes from cytokine 
addition. The functional role of this late activation h~s not yet been specifically addressed 
and could represent a likely and interesting continuation of the present work in the future. 
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Figure 3.1 ) NO/cGMP dependent inhibition of SMases and of TNF-a triggered early 
apoptotic signalling 
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3.2) Endogenous NO and TNF-a Signalling 
In the second part of my thesis I did focus my attention on the role of endogenous NO in 
the context of the TNF-a. signalling pathway. 
With the aim of studying the interaction between eNOS and TNF-a. signalling, we have 
generated, in collaboration with Stefania Bulotta (Faculty of Pharmacology; University of 
Catanzaro, Italy) a line of HeLa cells stably transfected with eNOS cDNA under the control 
of a doxycycline responsive element that allows a tight regulation of mRNA transcription 
and protein expression. HeLa cells were chosen for two reasons: because they express 
TNFRI and die by apoptosis when treated with TNF-a. (Castellino et aI, 1997) and 
because they are devoid of any endogenous NOS. In the HeLa system, therefore, the role of 
eNOS in cell death could be investigated after the introduction of the enzyme in a highly 
internally regulated model. 
As a first step, my research project involved an extensive characterization of the cell line, in 
order to check both the stability of the system and whether eNOS was correctly and 
functionally expressed upon doxycycline removal from the culture medium. 
By western blot analysis I showed that expression of the protein, absent in the presence of 
doxycycline, was switched on already 4-6 hours from antibiotic removal, reaching a steady 
state of expression after 72 hours. The latter was therefore the time point chosen for all 
successive experiments. The level of expression of eNOS was inversely proportional to the 
concentration of the antibiotic, with repression occurring with as little of 0.1 ng/ml of 
doxycycline. The system appears therefore highly controlled in term of expression of the 
protein. By immunocytochemistry the expressed enzyme was found to be localized mainly 
at the plasma membrane and in the Golgi area, as indicated in the literature for the 
endogenous enzyme (Sessa et aI, 1995). 
In terms of enzymatic activity, assayed by the arginine/citrulline assay, HeLa tet-off cells 
showed a Ca2+ -dependent activity in both cellular extract and intact cells, only when 
cultures were carried out in absence of dox. In these cells the levels are comparable to those 
in cells endowed with a native endogenous enzyme, such as the endothelial line E2. As 
expected, dox+ cells, not endowed with eNOS expression, don t display this activity. To 
this eNOS activity corresponded production ofbioavalable NO and formation of formation 
of cGMP, which was introduced in the system by cell reporter experiments with the rat 
pheochromocitoma cells, PC 12. 
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Taken together, these data indicate that our eNOS, when induced in HeLa cells, retains 
features of native enzyme, in terms of intracellular localization and enzymatic activity 
(Sessa et aI, 1995; Fulton et ai, 1999). 
The eNOS Tet-off cells so represent a clean, tightly and internally controlled system to 
study the eNOS role in TNF signalling and its effect of apoptotic cell death. In fact, any 
difference between cells cultured with or without doxycycline could be directly accounted 
to the enzyme expression. In the case of TNF-a. induced apoptosis, when the gas was 
administered together with, or prior to, the cytokine had only been shown either by using 
either NO donors (see the first part of this thesis and Denadai et ai, 2000) or by 
constitutives fluxes of endogenous NO, generated by expression of inducible NOS 
introduced by adenoviral gene transfer (Kim et ai, 1997; Dimmeler et ai, 1997; Li et ai, 
1999). 
The latter studies were inadeguate to establish directly whether an effective relationship 
exist between TNF-a. signalling and eNOS, and whether generation of NO represent a 
physiological built-in system triggered by the apoptotic stimuli itself, in order to modulate 
its own signalling. To elucidate these aspects I have studied cell death induced by TNF-a. in 
the usual paradigm of cell death, i.e. in the presence of the protein synthesis inhibitor 
cycloheximide, comparing cells expressing eNOS or not. 
Induction of eNOS was able to reduce significantly TNF-a. triggered cell death, albeit not 
abolishing it. Remarkably, the partial protection was removed if cells were treated 
previously with the NOS inhibitor L-NAME, which in contrast had no effect on the basal 
level of cell death, indicating that eNOS action depends on the generation of NO upon 
death stimuli. eNOS expression, therefore, is both necessary and sufficient to protect cells 
from apoptosis, and this action required generation of NO. 
I then investigated whether this effect is due to a tonic, basal level of NO produced by 
eNOS during the apoptotic stimuli, or is instead due to a . acute·· stimulation of the enzyme 
by TNF-a.. Arginine/citrulline assays and western blot analyses carried out with an 
antibody able to recognise activated eNOS showed that TNF-a is able to acutely activate 
the enzyme already in the first minutes of the treatment. These results demonstrate that in 
cells endowed with eNOS the apoptotic program stimulated by the cytokine is modulated 
through the autocrine generation of eNOS. Since, however, eNOS activation by TNF-a had 
not been described yet, thus, I decided to characterize further the signaling mechanism 
underlying the action of the cytokine. 
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A . classical"" Ca 2+ -dependent step does not seem to be involved in this signalling, since 
TNF-a treatment does not increase [Ca2+Jc. By contrast, eNOS activation correlated with 
the phosphorylation of Akt on Ser 473 and of eNOS on its Ser 1779, which are post-
translational modifications known to activate these enzymes. 
Signalling, however, is different from those activated by other stimuli such as: shear stress, 
estrogen, vascular endothelial growth factor, insulin, sphingosine-I-phosphate, which have 
been shown to activate eNOS through a Pi3K1AKT-dependent pathway (Fulton et ai, 1999; 
Dimmeler et ai, 1999; Haynes et ai, 2000; Fleming et ai, 2001; Harris et ai, 2001; 
Igarashi et ai, 2001). 
In the case of TNF-a activation of eNOS the difference is clearly indicated by the 
experiments where I compared the time-course of eNOS activation with those triggered by 
EGF, a direct activator of Pi3K pathway. This difference concerned the pattern of activation 
(and inactivation) of eNOS: EGF triggered a rapid activation of eNOS that was already 
detectable after 2 minutes, both by western blot analysis and by an arginine/citrulline assay. 
In contrast, activation of eNOS induced by TNF-a occurred with delay of 4-6 minutes, 
consistent with the delayed activation of Akt . 
This delay in eNOS activation suggests that the activation of eNOS by TNF-a is caused not 
by a direct, but by an indirect event. I therefore decided to analyze SMase role in this 
context, and this for several reasons: ceramide is generated by TNF-a after few minutes 
from the stimuli (Hannun 1996); data in the literature indicate that in various cell systems 
ceramide and SMases have a role in the activation of Pi3K1Akt. Remarkably, in all these 
studies the activation of Akt was shown to initiated 4-5 minutes from the stimuli (Ibitayo 
et ai, 1998; Hanna et ai, 1999; Plo et ai, 1999; Huang et ai, 2001; Monick et ai, 2001); 
finally, reports in the literature showed that exogenous short chain analogues of ceramide 
can activate eNOS (Igarashi et ai, 1999) while ceramide analogues, added to isolated 
blood vessels, lead to vasorelaxation, an effect which has classically abscribed to NO 
(Johns et ai, 1998). 
Data obtained by the using of various SMase inhibitors, support a specific role for N-SMase 
in the activation of eNOS. In addition the use of N-SMase inhibitors, together with the 
Pi3K inhibitor wortmannin, allowed us to establish that the eNOS pathway of activation 
occurs through a sequential involvement first ofN-SMase and then ofPi3K1Akt. 
This emerged from the following three observations: 
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I) Inhibition of both N-SMase and Pi3K are sufficient to block TNF-a triggered eNOS 
activation 
2) Inhibition ofN-SMase inhibits Akt activation by TNF-a 
3) Inhibition of Pi3K does not affect N-SMase activation triggered by TNF-a 
We still don t know whether the effects are mediated by a direct action or mediated 
downstream by a metabolite, such as sphingosine-I-phosphate. The latter had already been 
already suggested to activate eNOS through a mechanism not fully clarified, which appears 
to include the activation a type of cell surface receptors, the EDG receptors. 
At variance with those obtained with EGF, our results with TNF-a, also show that eNOS 
activation is switched-off prior to that of Akt. An attractive hypothesis for the time 
dissociation between Akt and eNDS activation by TNF-a is that the TNF-a/N-SMase mode 
of activation might include the switching on of a signal transduction pathway capable of 
selectively dephosphorylating, and thus inactivating, eNOS: this might explain the shorter 
duration of activation of the enzyme by TNF-a in comparison to a direct stimulus such as 
EGF, which doesn t involve the activation of SMase. The latter enzyme had indeed been 
shown to activate protein kinases and phosphatases, including members of the mitogen 
activated protein kinase family, protein Kinase C-~ as well as protein phosphatases I and 
2A (Kolesnick and Kronke, 1998; Perry and Hannun, 1998; Levade and Jaffrezou, 
1999). 
In principle, all of these molecules might be involved in eNOS de-activation, either directly 
or through an intermediate player. A likely candidate might be protein phosphatase 2A 
since this enzyme has been proposed to have a specific role in de-phosphorylating eNOS at 
Serll79 (Fleming et ai, 2001). In the future, further studies will address this question, 
investigating also the consequences in term of cellular signalling, of the different pattern of 
eNOS activity induced by different stimuli. 
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Figure 3.2) TNF-a activates eNOS through a N-SMase/Pi3KJAkt dependent signalling 
pathway. 
Discussion 106 
3.3) Cross Talk between NO and Ceramide: a Hypothesis 
In the work that was preliminary to the first part of this thesis we found that generation of 
ceramide by TNF-a contributes to apoptosis, at least in part due to a previously unreported 
effect, i.e. the potentiation of the recruitment of TRADD to TNF-R I and activation of 
caspase-8, two events that take place shortly (minutes) after receptor activation. As I 
demonstrated in the first part of the thesis exogenous NO, through a cGMP-dependent 
inhibition of A-SMase and of the early wave of ceramide generated by this activity, is able 
to inhibit these effect of ceramide. 
In the second part of the thesis I showed that in cells endowed with a functional eNOS, 
TNF-a rapidly induces a production of NO, which is dependent on the cytokine-induced 
activation first ofN-SMase and then ofPi3K1Akt. 
Tnf-RI, N-SMase and eNOS have all been reported to reside in caveolae at the plasma 
membrane (Sowa et ai, 2001; Veldman et ai, 2001). The functional link among them may 
therefore reflect their morphological association. Experimental evidence suggest that these 
molecules may interact to constitute a physiological signalling complex active when eNOS 
is present, as it is in the case of HeLa dox- cells. The link we have shown might have broad 
significance not only in physiology but also in pathology. A recent report in a rat model of 
portal hypertensive gastropathy indicates that TNF-a also activates eNOS in endothelial 
cells (Kawanaka et ai, 2002). eNOS and SMases appear therefore to generate a 
NO/ceramide-based, two-messenger system, triggered by TNF-a to regulate, in a bi-
directional way, the initial steps of its own signalling pathway. 
The scheme proposed in Fig 3.3 reports a hypothetical model ofTNF-a, SMase and NOS 
interaction, based on these results. TNF -a, through its class 1 receptor, is able to activate a 
complex series of signalling partners, among which SMase. Ceramide, generated from A-
SMase activity, is able to potentiate proximal events of the apoptotic signalling, such as 
TRADD recruitment and caspase-8 activation. In parallel, in the presence of a functional 
eNOS, N-SMase activation induces the generation of lipid messengers that activates the 
enzyme to produce NO, which therefore will play a protective action on the apoptotic 
signalling. 
In spite of the model, many question remain still open. For example, we do not understand 
the reason for the dichotomy of effect of the activation of the two SMases, with A-SMase 
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playing a detrimental and N -SMases playing a protective role in the context of regulation of 
TNF-a triggered cell death. A possible explanation might be topological, based on the 
differently localized generation of ceramide (or of its degradation products) with ensuing 
differential effects. 
Additional experiments are thus needed to clarity this point and to reconstitute the cellular 
signalling system we have unraveled by the use of different cellular and bio-molecular 
tools, including dominant negative mutants of both form of SMases (as soon as they 
become available) and of Pi3K. These experiments will permit to assess unambiguosly the 
role of the different SMases isoforms in the context ofTNF-a signalling, and to understand 
better its role in physiology and pathology. 
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Figure 3.3) Hypothetical model of cross-talk between NO and SMase in regulation of 
TNF -<X triggered apoptosis 
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Chapter 4 
MA TERIALS AND METHODS 
4.1) Materials 
The following reagents were purchased where indicated: 
Antibodies: 
• Monoclonal anti-~-actin from Sigma (Saint Louis, MS, USA) 
• Monoclonal anti-eNOS from Transduction Laboratories (Lexyngton, United Kingdom) 
• Polyclonal fluorescein-labeled anti-mouse IgG and rhodamine-conjugated anti-rabbitt 
IgG from lackson Immunoresearch Laboratories (West Grove, PA, USA) 
• Polyclonal anti-giantin was a kind gift of Dr. M. Renz (Institute of Immunology and 
Molecular Genetics, Karlsruhe, Germany) 
• Polyclonal anti-mouse and anti-rabbit Horseradish Peroxidase (HRP) coupled 
antibodies from Biorad (Hercules, CA, USA) 
• Polyclonal anti-phospho(Ser I 177)-eNOS, anti-phospho-Akt (Ser 473) and anti-Akt 
from Cell Signaling Technology (Beverly, MA, USA) 
• Polyc1onal anti-procaspase-8 and anti-procaspase-3 from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA) 
Reagents: 
• [N-methyl-14C]-sphingomyelin, [14C]-thymidine, L-[13H]-thymidine, e2p]-ATP and the 
Enhanced Chemiluminescence (ECL) kit from Amersham Corporation (Little Chalfont, 
United Kingdom) 
• Bicinchonic Acid Assay (BCA kit) from Perbio (Bezons, France) 
• Bovine eNOS cDNA was a kind gift of Dr. William C. Sessa (Yale University School 
of Medicine, New Haven, CT, USA) 
• Cl6 ceramide, cycloheximide (CHX), Imipramine, Ly294002, Manumycin A, 
Monensine, Wortmannin, and all other chemicals were from SIGMA (St.Louis, MO, 
USA) 
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• Cell culture media were from GIB CO (Basel, Switzerland) except for foetal clone Ill, 
obtained from Hyclone-Celbio (Milan, Italy) and for Tet System-Approved foetal 
bovine serum (FBS) obtained from Clontech (Palo Alto, CA, USA) 
• FITC-Iabeled Annexin-V from Boehringer Mannheim (Basel, Switzerland) 
• Hela Tet-Off cells were from Clontech (Palo Alto, CA, USA) 
• N -acetyl-IETD-7 -amino-4trifluoromethylcoumarin from Eppendorf (Hamburg, 
Germany) 
• Nitro-cellulose filters from Schleicher & Schuell (Dassel, Germany) 
• Oregon green 488 phalloidin from Molecular Probes (Leiden, the Netherlands) 
• Protease inhibitor cocktail Complete, Roche Diagnostics (Basel, Switzerland) 
• Recombinant human TNF-a, H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-l-one (ODQ) from 
Alexis (Florence, Italy) 
• Scyphostatin was a kind gift of Dr. T Ogita (Sankyo Ltd., Tokyo, Japan) 
• Tricyclodecan-9-yl xanthate (D609), S-nitroso-acetylpenicillamine (SNAP), C2 and C16 
ceramide from Calbiochem (Bad Soden, Germany) 
4.2) Cell culture and treatments: 
U937 cells were routinely grown at 37°C, 5% C02, in RPMI medium 1640 supplemented 
with 10% heat-inactivated foetal clone III serum, 2 mM glutamine, 100 units/ml 
streptomycin, and 100 units/ml penicillin and used within the 10th week from thawing. All 
following experiments were carried out in the above culture medium. 
HeLa Tet-off cells were grown in Dulbecco's modified Eagle medium (DMEM) 
supplemented with 10 % Tet System Approved FBS, 50 VI/ml penicillin, 50 Jlg/ml 
streptomycin, 2 mM L-glutamine, 200 Jlglml G418, 200 Jlglml Hygromicin and maintained 
at 37°C under a 5 % C02 atmosphere. 
PC12 cells were grown at 37°C, 5% C02 in DMEM supplemented with 10% heat-
inactivated horse serum and 5% Fetal Clone 11. 
Preincubations with SNAP (1-300 flM) , ODQ (1 JlM), 8-Br-cGMP (3 mM), monensin (1 
flM), scyphostatin (1 flM), D609 (25 flg/ml), manumycin A (5 J,1M), L-carnitine (10 flg/ml), 
wortmannin (lOO nM), LY 294002 (5 J,1M), NO}-nitro-L-arginine methyl ester (L-NAME; 
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0.5 mM) were for 15 minutes prior to TNF-a. (lOO ng/ml), EGF (100 ng/ml) or ATP (100 
JA.M) administration, or as indicated in the pertinent figure legend; Imipramine pre-
treatment (20 JA.M) was for Ih. SNAP was used at concentrations inducing no cytotoxicity 
effects and D609 under conditions not stimulating ceramide generation (DeNadai et ai, 
2000) 
Cells were incubated in the presence of the various compounds throughout the experiments. 
4.3) Measurement of SMase activities in U937 cells 
SMase assays were performed essentially as reported in Wiegmann et ai, 1994. Following 
pre-incubation with various drugs, cell samples (2 x 106 cells) were treated with TNF-a. (50 
ng/ml at 37°C). Incubations were stopped at the indicated time-points by immersion of 
reaction tubes in a methanol/dry ice bath. Cells were then centrifuged (1000 g for 5 min at 
4°C) and the pellet washed once with ice-cold phosphate buffered saline. 
To assay the A-SMase activity cell pellets were resuspended in 0.2 ml of 0.1 % Triton x-
100 at 4°C for IS min and subsequently homogenised by repeated squeezing through an 18-
gauge needle. Homogenates were then centrifuged (1000 g for 5 min at 4°C) in order to 
remove nuclei and cellular debris, and the supematant was incubated for 2 h at 37°C in a 
buffer containing: 250 mM Na acetate, 1 mM EDTA, [N-methyl-14C]-sphingomyelin (55 
mCi/mmol; 50000 dpm/assay), pH 5.5. 
To assay N-SMase activity, cell pellets were resuspended in 0.2 ml of a buffer consisting 
of: 0.2 % Triton X-100, 20 mM HEPES, 10 mM MgCh, 2 mM EDTA, 5 mM dithiothreitol, 
0,1 mM Na3 V04, 30 mM p-nitrophenylphosphate, 10 mM ~-glycerophosphate, 750 JA.M 
ATP, 1 mM phenylmethylsulfonyl fluoride, 10 mM leupeptin, 10 mM pepstatin, 5 mg/ml 
soy bean trypsin inhibitor and 2 mg/ml aprotinin, pH 7.4. After 5 minutes incubation on ice, 
cells were homogenised as above. Cell lysates were then incubated for 2 h at 37°C in a 
buffer containing 20 mM HEPES, 1 mM MgCh 'and [N-methyl-14C]-sphingomyelin (55 
mCi/mmol; 50000 dpm/assay), pH 7.4. 
Reactions for both A-SMase and N-SMase were stopped by addition of 250 J.1L of ice-cold 
CHCh:MeOH (2: 1, vol:vol) and 250 J.1L of ice-cold H20. Phosphorylcholine thus produced 
was separated from sphingomyelin by sequential washing with 800 JA.L of ice-cold 
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CHCh:MeOH (2:1, vol:vol), 500 J.lL of CH Cl) and 750 J.lL ofCHCl):MeOH:H20 (2:47:48, 
vol:vol:vol). 
Aqueous and orgamc phases were then collected separately and radioactive 
phosphorylcholine in the aqueous phase counted by liquid scintillation in a Beckman f3-
counter. Non-hydrolysed, radioactive sphingomyelin in the organic phase was routinely 
measured as an internal control. To check for the specificity of the assay conditions 
samples containing either purified A-SMase or N-SMase (Sigma) were assayed in parallel 
as positive controls. Results were normalised to the protein content evaluated by the BCA 
assay. 
4.4) Apoptosis detection in U937 cells 
4.4a) Western blot analyses of procaspase-8 and 3 in U937: 
Cell lysates were prepared from aliquots of 2x 1 06 cells. After pertinent treatments, cell 
aliquots were put on ice, washed rapidly twice with 150 mM NaCI, 1 mM EDTA, 2 mM 
Na2P206, 30 mM NaF, 20 mM Hepes, pH 7.5 and lysed in the same buffer containing 1% 
Triton X-lOO, 0.1 mM phenylmethylsulphonylfluoride, 10 mg/mlleupeptin and 10 mg/ml 
aprotinin. Lysates were centrifuged at 3000 rpm for 5 minutes and the supernatants were 
transferred to other vials. Protein concentration of the samples was assessed by using the 
BCA procedure. 
The Western blot analyses were carried out on 30 mg of soluble proteins separated on 12% 
SDS-PAGE and transferred onto nitro-cellulose membranes. Nonspecific binding was 
blocked before immunolabeling by incubation for 1 h at room temperature with blotting 
buffer (PBS containing 0.1 % Tween and 5% nonfat milk). The membranes were incubated 
overnight in blotting buffer supplemented with the anti-procaspase-8; after this incubation 
membranes were washed for 1 h with blotting buffer. The secondary HRP labelled antibody 
then was added for 30 min. After several washes pf the membranes in blotting buffer, the 
antigens were revealed by autoradiography with EeL according to the manufacturer's 
instructions. As an internal control, the membranes were subsequentely stripped off of the 
first antibody and reprobed with the antibody recognising procaspase-3. Stripping was 
carried out by incubating nitrocellulose filters for 30 min at 52°C with a buffer consisting 
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of: 62.5 mM Tris-HCI, 2% SDS, 1% ~-mercaptoetanol, pH 6.7; filters were then washed 
extensively in 100 mM Tris-HCI, 0.1 % Tween 20, pH 7.4, before equilibration for Ih in 
blotting buffer and reprobing ofthe membrane with the appropriate antibody. 
4.4b) Measurement of caspase-8 activity in U937 cells 
Aliquots of 2 x 106 U937 cells, pre-incubated with the various drug treatments described 
above, were treated for 5 minutes with TNF-a C;O ng/ml) in the presence of CHX (1 
Ilg/ml), washed in ice cold 150 mM NaCl, 1 mM EDTA, 2 mM Na2P206, 30 mM NaF, 20 
mM HEPES, pH 7.5 and lysed in the same buffer containing 1 % Triton X 100, 0.1 mM 
phenylmethylsulphonylfluoride, 10 Ilg/ml leupeptin and 10 Ilg/ml aprotinin. Protein 
concentration of the samples was assessed by BCA assay. 
100 Ilg of soluble proteins were then diluted in a reaction buffer containing a final 
concentration of25 mM HEPES, 100 mM NaCl, 5 mM dithiothreitol, 1 mM EDTA, 0.1% 
CHAPS and 10% sucrose. Caspase-8 activity was assayed in a Perkin-Elmer LS50 
fluorimeter, equipped with 400 nm excitation and 505 nm emission filters, by measuring 
for I h at 37°C the fluorescence emitted by the cleaved specific caspase-8 substrate, N-
acetyl-IETD-7-amino-4-trifluoromethylcoumarin (25 IlM), calibrated with respect to a 7-
amino-4-trifluoromethylcoumarin concentration curve 
4.4c) DNA fragmentation 
Secondary DNA fragmentation following TNF-a/CHX treatment was quantitatively 
measured as described in Sestili et ai, 1996. Cells were labelled overnight with [14CJ_ 
thymidine (0.05 IlCi/ml) and incubated for a further 6 h in a medium containing unlabelled 
thymidine (1 Ilg/ml) before pre-incubation with or without the various compounds and 
treatment with TNF-a (50 ng/ml) plus CHX (1 Ilg/ml). At the indicated time-points the 
cells were sedimented (1000 rpm, 5 min at 4°C) and the pellet was resuspended in a buffer 
solution containing: 140 mM NaCI, 5 mM KCI, 5 mM glucose, 5 mM EDTA, 4 mM Na 
HC03, pH 8.3. Aliquots of 0.5 x 106 cells were then loaded onto protein adsorbing 
(polyvinylchloride) filters (25 mm, 2 Ilm pore), washed with the same buffer and lysed with 
a solution containing 0.2 % sarkosyl, 2 M NaCI and 40 mM EDTA, pH 10.1. Filters were 
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rinsed with EDTA (20 mM, pH 10.1) and then removed from the filter holders which were 
washed twice with 0.4 N NaOH. Radioactivity was counted in the lysates, EDTA washes, 
filters and filter holder washes. For each sample, the DNA fragmentation was determined 
14 
as the percentage of the C-Iabeled DNArecovered in the lysate plus the EDTA washes. 
4.4d) Annexin-V staining 
Cells, pretreated and exposed to TNF-a as indicated in the previous sections were analyzed 
for phosphatidylserine exposure at the external surface of the plasma membrane. 
Aliquots of 5xl04 cells were stained with fluorescein isothiocyanate-labeled(FITC)-
Annexin V (0.5 mg/ml in phosphate buffered saline) for 15 minutes at room temperature, 
after the indicated TNF -a. time treatment and with the various indicated pretreatment. 
Single cell Annexin V positive staining was then evaluated using a fluorescence-activated 
cell sorter (F ACStar Plus, Becton Dickinson, Sunnyvale, CA, USA) 
4.5) Transfection and selection of eNDS conditionally expressing HeLa cells 
Cells grown on 35 mm Petri dishes to - 40% confluence were co-transfected by the 
calcium phosphate method (DeSilvestris et ai, 1995) using 0.5 J.1g of pTRE/eNOS plasmid 
and 25 ng of pTK-Hygr plasmid (Clontech) per cm2 of culture dish. Three days after 
transfection, the cells were detached with trypsin and plated on Petri dishes in the presence 
of doxycycline hydrochloride (0.01-1 J.1g/ml) and hygromycin B (200 J.1g/ml). After 3 
weeks, hygromycin-resistant colonies were expanded in 24-well Petri dishes. Stable 
transfectants were maintained in medium supplemented with 100 J.1g/ml 0418, 100 J.1g/ml 
hygromycin and 1 J.1g/ml doxycycline. 
To induce expression of eNOS, cells were plated in the absence of doxycycline: unless 
otherwise specified, experiments were carried out on cells cultured for 72 h with or without 
the antibiotic. 
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4.6) Western blot analysis in HeLa cells 
After the various treatments, cells mono layers in the presence or absence of doxycycline 
were washed free of medium and solubilised by direct addition of a pre-heated (to 80°C) 
denaturing buffer, containing 50 mM Tris-CI pH 6.8, 2% SDS and a protease inhibitor 
cocktail. Solubilised samples were collected and immediately boiled for 2 min. 
Bromophenol blue, glycerol and ~-mercaptoethanol were then added to final concentrations 
of 0.05%, 10% and 2%, respectively. 
Samples were boiled again before loading onto 10% SDS-polyacrylamide gels. After 
electrophoresis, polypeptides were electrophoretically transferred to nitro-cellulose filters. 
Monoclonal anti-eN~S (dilution 1: 1000 in 3%BSAIPBS), polyclonal anti-phospho eNOS 
(dilution 1:1000 in 3%BSAlPBS), mono clonal anti-Akt (dilution 1:1000 in 3%BSAlPBS), 
polyc1onal anti-phospho Akt (dilution 1:1000 in 3%BSAlPBS) and mono clonal anti-~-actin 
(dilution 1: 1000 in 3%BSAIPBS)antibodies were used to reveal the respective antigens. 
After incubation with appropriate secondary reagent, the antigens were revealed by 
autoradiography with ECL procedure. 
4.7) Immunofluorescence in HeLa cells 
HeLa cells plated on glass coverslips and grown in the presence or absence of doxycycline, 
were fixed with 4% paraformaldehyde in 120 mM Na2P206, pH 7.4, for 30 min at 37°. The 
monolayers were then permeabilized with Triton X-lOO and processed as described in De 
Silvestris et al (1995). In some experiments cells were immunostained with only 
monoc1onal anti-eNOS antibody; in others they were were doubly immunostained with 
monoclonal anti-eN~S antibody (dilution 1: 100) and polyclonal anti-giantin antibody 
(dilution 1: 100), to stain the Golgi complex. Bound monoclonal and polyclonal antibodies 
were then revealed by fluorescein-Iabelled anti-m<?use IgG and rhodamine-conjugated anti-
rabbit IgG. 
To reveal actin filaments, cells were stained with a fluorescent derivative of phalloidin 
toxoid, Oregon green 488 phalloidin (Molecular Probes): in this case the eNOS 
immunostaining was revealed by the use of a rhodamine-conjugated anti-mouse IgO. 
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Coverslips were observed under a NIKON Optiphot 2 microscope equipped for 
epifluorescence or with a BIO-RAD MRC 1024 laser confocal microscope. 
4.8) Measurement of (Ca2+]c in HeLa cells 
Cells were detached by trypsinisation, washed in a Krebs Ringer HEPES buffer containing 
125 mM NaCl, 5 mM KCl, 1.2 mM KH2P04 , 1.2 mM MgS04 , 2 mM CaCh, 6 mM 
glucose, 25 mM HEPES-NaOH, pH 7.4, and loaded in the same buffer with the Ca2+_ 
sensitive dye, fura-2 (4.5 ~M), administered as acetoxymethylester for 30 min at 25°C. 
Cell preparations were then diluted (5 x 106 cells) and [Ca2+]c, before and after challenge 
with either ATP, EGF or TNF-a, was analysed in a Perkin Elmer LS-50B fluorimeter as 
described (Clementi et ai, 1995). 
4.9) NOS activity assays in HeLa cells 
NOS activity was quantified by measuring the conversion of L-eH] arginine into L-eH] 
citrulline in both homogenised and intact cells. In the first approach, cells cultured in the 
presence or absence of doxycycline were detached by trypsinisation, pelleted and 
resuspended (2 x 107 cells/ml) in an homogenisation buffer containing: 320 mM sucrose, 1 
mM dithiothreitol, 1 mM EDTA, 20 mM HEPES, pH 7.2, supplemented with a protease 
inhibitor cocktail. After homogenisation by sonication (30 sec at 4°C), 50 J.ll of cell extract 
were added to 100 J.lI of a reaction buffer containing: 1.2 mM MgCh, 10 J.lM 
tetrahydrobiopterin, 1 J.lM FAD, 1 J.lM FMN, 1 J.lM NADPH, 0.45 mM CaCh, 10 J.lg/ml 
calmodulin, 50J.lM L-eH] arginine (0.8 J.lCi/sample) and 25 mM Tris, pH 7.4. The reaction 
was carried out for 10 minutes at 37°C and stopped by the addition of 2 ml of 50 mM 
HEPES, pH 5.5, supplemented with 5 mM EGTA. Samples containing either Nffi-
monomethyl-L-arginine (L-NMMA; 500 J.lM) or EGTA (I mM) in the reaction buffer were 
processed in parallel as controls. 
NOS activity in intact cells following pre-incubation with various compound as indicated in 
the section on Cell culture and treatments, was instead measured on mono layers washed 
and then incubated for 20 min at 37°C with a reaction buffer containing, in addition to the 
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inhibitors: 145 mM NaCl, 5 mM KCI, 1 mM MgS04, 10 mM glucose, I mM CaCh and 10 
mM HEPES, pH 7.4. 
In the experiments measuring eNOS activation by TNF -a, ATP or EGF, 2.5 IlCi/ml of L-
eH] arginine was added 1 min before stimulation with the cytokine. 
In the experiments aimed at comparing the kinetics of eNOS activation by TNF-a, ATP or 
EGF we used the same protocol except for the fact that 2.5 IlCi/ml of L-eH] arginine was 
added at various time-points after administration of each eNOS activating compound and 
the reaction stopped after 2 min. Non-stimulated cells were always run in parallel as 
controls. 
The reaction was then stopped at the various indicated time points by washing the 
mono layers with 2 ml of ice-cold phosphate buffered saline, pH 7.4, supplemented with L-
arginine (5 mM) and EDTA (4 mM). 0.5 ml of 100% cold ethanol was added to the dishes 
and left to evaporate before a final addition of 2 ml of 20 mM HEPES, pH 6.0, to resuspend 
the formed radioactive product (L-Citrulline) as well as the unconverted radioactive 
substrate. The separation of L-eH] citrulline from L-eH] arginine was obtained by 
DOWEX 50X8-400 chromatography as described in Bredt and Snyder, (1989). 
In the assay carried out with homogenised cells, values obtained from samples incubated 
without cell extracts were subtracted. Data in the intact cells are presented without 
background correction. L-eH] citrulline formed was normalised to protein content as 
determined by the BCA assay. 
4.10) cGMP measurements in HeLa cells 
NO-dependent guanosine 3',5' -cyclic monophosphate (cGMP) generation by the 
transfected HeLa clone Ad was measured in both the cells themselves and in a concubation 
system using PC12 cells as a reporter system: samples of suspended 2x106 HeLa cells and 
0.5x 106 cells, either separate or together, were. treated for 15 minutes at 37°C in the 
presence or absence of either A TP Cl 00 J,1M), TNF -Cl (100 ng/mt) or S-
nitrosoacetylpenicillamine (lOO J,1M) in 1 ml of a solution containing 125 mM NaCI, 5 mM 
KCI, 1.2 mM MgS04, 1.2 mM KH2P04 , 2mM CaCh, 6 mM glucose, 1 mM L-arginine, 0.6 
mM isobuthylmethylxanthine (IBMX) and 25 mM HEPES, pH 7.4, with or without L-
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NAME (0.5 mM). The reaction was terminated by addition of ice-cold trichloroacetic acid 
(final concentration 6%). After ether extraction, cGMP levels were measured using a 
radioimmunoassay kit (Perkin Elmer Life Sciences) and normalized to cellular proteins 
with the BCA assay. 
4.11) Apoptosis detection in HeLa cells 
Apoptosis was measured by flow cytometry using two different protocols as described in 
Sciorati et ai, 1997. In the first approach, phosphatidyl serine exposure was monitored by 
staining for 15 min at room temperature with FITC-Iabelled annexin V (0.5 J,lg/ml in 
phosphate buffered saline). The loss of the ability to exclude vital dyes was assessed using 
propidium iodide in an isotonic buffer (10 mg/ml in phosphate buffered saline). Early 
apoptotic cells exclude the dye but are stained with annex in V, whereas non apoptotic cells 
are negative for both. 
In the second approach the hypodiploid DNA peak in single parameter DNA histograms 
typical of apoptotic cells was identified. To this end DNA was stained in unfixed cells 
incubated for 60 min at 37°C in sodium citrate 0.1%, propidium iodide (50 mg/ml), RNAse 
A (lOO J,lg/ml; Sigma) and Nonidet P40 (0.01%). 
Cells were analysed for either DNA content or annexin V staining using a fluorescence-
activated cell sorter (F ACStar Plus, Becton Dickinson, Sunnyvale, CA). 
4.12) Statistical analysis 
The results are expressed as means ± standard error of the mean (s.e.m .. ); n represents the 
number of individual experiments. Statistical analysis was carried out using the Student's t 
test for unpaired variables (two-tailed). The asterisks *,** or *** or by +, ++ and +++ refer 
to statistical probabilities (P) of < 0.5, < 0.01 a,nd < 0.001, as indicated in the various 
legend to figures or tables. 
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